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Objectives: Based on the analysis of electromyographic (EMG) data muscles are often characterized 
as normal or affected by a neuromuscular disease process. A clinical decision support system (CDSS) 
for the electrophysiological characterization of muscles by analyzing motor unit potentials (MUPs) 
was developed to assist physicians and researchers with the diagnosis, treatment & management of 
neuromuscular disorders and analyzed against criteria for use in a clinical setting.  
Methods: Quantitative MUP data extracted from various muscles from control subjects and patients 
from a number of clinics was used to compare the sensitivity, specificity, and accuracy of a number of 
different clinical decision support methods. The CDSS developed in this work known as AMC-PD 
has three components: MUP characterization using Pattern Discovery (PD), muscle characterization 
by taking the average of MUP characterizations and calibrated muscle characterizations. 
Results: The results demonstrated that AMC-PD achieved higher accuracy than conventional means 
and outlier analysis. Duration, thickness and number of turns were the most discriminative MUP 
features for characterizing the muscles studied in this work. 
Conclusions: AMC-PD achieved higher accuracy than conventional means and outlier analysis. 
Muscle characterization performed using AMC-PD can facilitate the determination of “possible”, 
“probable”, or “definite” levels of disease whereas the conventional means and outlier methods can 
only provide a dichotomous “normal” or “abnormal” decision. Therefore, AMC-PD can be directly 
used to support clinical decisions related to initial diagnosis as well as treatment and management 
over time. Decisions are based on facts and not impressions giving electromyography a more reliable 
role in the diagnosis, management, and treatment of neuromuscular disorders. AMC-PD based 
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A clinical decision support method for the electrophysiological characterization of muscles to assist 
physicians and researchers with the diagnosis, treatment & management of neuromuscular disorders 
is developed and analyzed against criteria for use in a clinical setting. The method is transparent, and 
more accurate than the conventional decision support discussed in the literature. 
1.1 Electromyographic Examination 
Muscles are composed of groups of motor units. A motor unit (MU) is a motor neuron and the muscle 
fibers it innervates. A motor neuron is composed of dendrites that attach to other neurons, a cell body 
that houses a single nucleus and a single axon that terminates into multiple axonal twigs - each twig 
synapses with a muscle fiber in a region known as the neuromuscular junction (NMJ).  
A motor neuron propagates impulses from the brain or spinal cord to muscle fibers to facilitate 
contraction of a MU.  The top portion of Figure 1.1 shows a representation of the anatomy of a motor 
unit and a needle electrode in close proximity to the motor unit.  The depolarization of a motor neuron 
will depolarize all of the muscle fibers that it innervates. The depolarization of a muscle fiber is 
known as a muscle fiber potential (MFP). The sum of all of the spatially and temporally dispersed 
MFPs arising from a depolarized MU generates changes in the voltage field in the extracellular 
volume surrounding the MU.  The size and shape of the voltage field detected over time is a function 
of the morphology, physiology and the position of the electrode relative to the MU. The voltage field 
detected from an active MU is known as a motor unit potential (MUP). A series of depolarizations 
generated by one motor neuron (shown as Dirac Delta Impulse Trains in Figure 1.1) will generate a 
series of MUPs which is known as a motor unit potential train (MUPT). The superposition of voltage 
fields generated by active MUs that are detected by a needle or surface electrode is called the 
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Physiological electromyographic (EMG) signal in Figure 1.1. Figure 1.1 shows that the number of 
MUPTs detected is p .   The Physiological EMG signal is denoted by ( )Ftmp ,  which is a function of 
time (t) and force of muscular contraction (F). Instrumentation introduces noise denoted by ( )tn  and 
the detected EMG signal is also affected by the filter characteristics denoted by )(tr of the 
instrumentation which leads to the observable EMG signal denoted ( )Ftm ,  at the bottom of Figure 
1.1. Neuromuscular disorders change the morphology and physiology of MUs causing changes in 
their activation patterns and MUP shapes and thus the EMG signals that they produce.  
There are two broad categories of disorders that affect neuromuscular systems: myopathic and 
neuropathic. Myopathic disorders occur when muscle fibers die or atrophy, e.g. Muscular Dystrophy. 
Neuropathic disorders occur when motor neurons die and the remaining surviving motor neurons re-
innervate orphaned muscle fibers, e.g. Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease).   Figure 
1.2 shows that in general the size and shape of MUPs detected from muscles affected by a myopathic 
disorder are smaller and more complex while the shapes of MUPs detected from neuropathic muscles 
are larger and more complex compared to MUPs detected from normal muscles. However, in practice 
there is a great deal of ambiguity in the interpretation of MUPs detected from a muscle as MUPs that 
appear normal, myopathic and neuropathic can be detected from any muscle regardless of its 
condition [1].  This ambiguity exists because of how widely muscle structure and needle position can 
vary. 
In current clinical practice the status quo characterization of muscle is mostly done using 
qualitative auditory and visual analysis of needle-detected EMG signals detected during low-level 
muscle contractions and focuses on the analysis of individual MUP shapes and MU discharge 
patterns. In auditory analysis a clinician listens for the frequency and amplitude of the clicks and 
crackles made by amplified EMG signals. The auditory patterns reflect the recruitment of MUs and 
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the shape of MUP waveforms - both of which can be used to infer the presence or absence of 
underlying disease processes. Auditory analysis is usually done alongside a visual inspection of the 
EMG signal. Visual inspection tools use triggering in an attempt to isolate MUPs detected from the 
same MU. The triggered MUP waveforms are superimposed and displayed in real time.  Qualitative 
visual inspection is a rough eyeball estimate of the shape of MUPs and how these compare to the 
expectation of being normal. According to several psychological studies qualitative examination is 
ambiguous and prone to misinterpretation [2, 3]. Both of these qualitative methods are crude with 
poor sensitivity and specificity, as well, they are lacking in providing objective quantitative data from 
which longitudinal comparisons can be easily made. For example, a recent study authored by Kendall 
showed that faculty and residents (blind to the underlying diagnosis of radiculopathy) using video 
recorded needle based examinations had an overall agreement of only 46.9% with the actual diagnosis 
[4].  
Quantitative electromyography (QEMG) is the process of detecting and quantitatively analyzing 
EMG signals for the extraction of clinically useful information. Through the use of EMG signal 
decomposition a comprehensive set of features can be accurately measured and displayed leaving a 
large amount of information to be interpreted. QEMG is not used as frequently as qualitative EMG in 
clinics. The author believes that interpretation of the exhaustive set of statistics generated by 
quantitative analysis of EMG signals can be improved by transforming the statistics into clinically 





Figure  1.1 Model of the composition of an EMG signal.  (From J. V. Basmajian, Muscles 
Alive: Their Functions Revealed by Electromyography. ,4 th ed. - ed. Baltimore: Williams & 




Figure  1.2 Effects of Disease on Motor Units & Motor Unit Potentials 
Below the letter A in the figure is an example of two normal MUs and a MUP detected from one of 
the MUs. The circle to the right of the letter A is the cross-section of the muscle showing the 
individual muscle fibres belonging to each MU. Below the letter B is an example of two MUs being 
affected by a neuropathic disorder and the MUP detected from the MU shaded dark. Below the letter 
C is an example of two MUs being affected by a myopathic disorder and the MUP detected from the 
MU shaded dark. (From E. Stalberg and B. Falck, "The role of electromyography in neurology," 




1.2 Objective & Approach 
Characterization is a clinical term referring to the discernment, description or attribution of 
distinguishing traits [5]. Figure 1.3 below shows the information flow in a QEMG based examination 
that is to be augmented by the proposed Clinical Decision Support System (CDSS). Starting at the top 
a disease process may affect a muscle’s morphology and physiology. An EMG signal is detected 
using an electrode that is inserted into a muscle. The signal is detected while the patient voluntarily 
contracts the muscle being examined. The method of QEMG analysis to be used in this work is the 
process of isolating MUPs that comprise the EMG signal and then extracting features of the shapes of 
the isolated MUPs.  The step after QEMG shows the CDSS that provides a characterization of the 
extracted features for the muscle from which they were detected. It is shaded to show that this is the 
focus of the proposed research. The physician analyzes the characterization and then can infer if a 
disease is affecting a muscle and its level of involvement. The effect of a disease over time will be 
able to be tracked with the aid of the proposed CDSS.  
The objective of this work is to augment existing QEMG techniques with a decision support 
system that transforms QEMG generated statistics into a concise muscle characterization that 
improves the ability of physicians to decide upon an appropriate clinical action. Pattern recognition 
techniques will be used to develop a characterization system. A system that has excellent sensitivity 
(true positives) and specificity (true negatives) when used to characterize muscle disorders would be a 
valuable addition to clinical practice.  
The CDSS developed in this work analyzes QEMG statistics to report the characterization of a 
single muscle. The CDSS has three components: MUP characterization, muscle characterization and 
calibrated muscle characterization.  MUP characterization calculates a set of conditional probabilities 
that a MUP is abnormal and normal given the features of the MUP detected from a muscle under 
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examination. Combining a set of MUP characterizations provides an overall muscle characterization. 
A muscle characterization is a set of scores representing the degree to which a muscle is normal and 
abnormal. The third component of the CDSS converts scores into calibrated muscle characterization 
conditional probabilities that accurately reflect the reliability or confidence of an individual 
characterization. In other words, a calibrated muscle characterization score of 80% probability of 
abnormality means that 80% of muscles that receive that conditional probability are truly abnormal.  
Calibrated conditional probabilities will help clinicians understand the level of confidence a CDSS 
has in its categorization of normality and abnormality of a muscle under examination.  
1.3 Overview of the Thesis 
Chapter 2 reviews QEMG methods used for muscle examination in clinical settings. The different 
methods are compared to justify focusing on MUP analysis. Then existing MUP characterization 
methods are described as well as existing muscle characterization methods that use MUP features. A 
section in Chapter 2 provides the requirements that CDSSs in general need to possess. These 
requirements guided the development and evaluation of the CDSS in this work.  Chapter 2 ends by 
describing potential pattern recognition techniques and discusses their suitably for use as MUP 
characterization methods against the CDSS requirements.  
Chapter 3 describes the various MUP data sets that were used to evaluate the CDSS developed for 
this work. The set of MUP features are defined as well as the measures used to evaluate the 
performance of the CDSS.  
Chapter 4 describes the MUP Characterization method used in this work known as Pattern 
Discovery (PD). The performance of PD was compared to other classifiers that are commonly used 
for medical diagnosis.  
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Chapter 5 analyzes the performance of various methods used for muscle characterization. 
Combining conditional probabilities, calculated by pattern recognition based MUP Characterization 
methods, into muscle characterizations are known as probabilistic muscle characterization methods. 
The performance of a number of probabilistic muscle characterization methods are compared with 
conventional muscle characterization techniques across an exhaustive set of feature sets and for the 
various MUP data sets.  
Chapter 6 describes another muscle characterization method – the Z transform. Then a method of 
calibrating muscle characterizations that converts raw muscle characterization scores into conditional 
probabilities is described. The performance of the calibration method was compared across two 




























Background and Related Work 
2.1 Quantitative EMG Overview 
Quantitative EMG (QEMG) is the use of quantitative based methods to analyze and extract features 
from EMG signals to augment the determination of underlying disease processes. QEMG analysis 
offers objective, quantitative analysis that can allow comparisons with reference data collected from 
subjects of the same age and gender as the patient. There are four main approaches for quantitatively 
studying the electrical activity of muscles contracted voluntarily by the patient. The first approach 
known as MUP analysis is based on studying the shapes and sizes of isolated MUPs. The second 
approach is based on studying the composite EMG signal also known as the interference pattern (IP). 
The third approach estimates the number of motor units in a muscle. The fourth examines the stability 
of the operation of the neuromuscular junction. 
2.1.1 MUP Analysis 
The contraction of a muscle leads to the discharge of recruited motor units. A sustained contraction at 
a constant level of force leads to the repeated discharge of these MUs. The series of MUPs associated 
with a MU is known as a MUP train. The composite EMG signal is the superposition of all of the 
MUP trains of active MUs. Neuromuscular disorders change the morphology and physiology of MUs 
causing changes in their activation patterns and MUP shape and size.  As well the orientation and 
proximity of the electrode relative to the active MUs affects the size and shape of detected MUPs.  
Several techniques are available for the extraction and analysis of isolated MUP waveforms. One 
that is in current widespread use is amplitude triggering. MUPs that exceed an amplitude threshold 
can be triggered for view on a screen. This method is used to capture a set of MUPs that exceeds an 
amplitude threshold. To capture MUPs of differing amplitude a window trigger mechanism was 
 
 11 
developed [6]. MUPs whose peak amplitude falls within a specified range can be isolated for view on 
a screen. Repeated triggering of MUPs that fall within this range can be averaged to remove noise 
from interfering MUPs not belonging to the MUP train of interest. However, MUPs detected from 
different MUs whose peak amplitude falls in the same range may also trigger the display making it 
harder to isolate MUP trains. Amplitude triggering requires a great deal of time and patient 
cooperation if a large number of MUPs are to be sampled.  
Another method of isolating MUPs is known as decomposition based MUP analysis. This method 
involves the detection, clustering and then the supervised classification of MUPs into MUP trains [7]. 
A MUP is detected when it exceeds threshold levels - usually based on amplitude and slope. MUPs in 
the first several seconds (initialization interval) of the EMG signal are clustered using the K-means 
algorithm. The clustering algorithm produces an estimate for the number of active motor units and a 
prototypical shape of their MUPs. Supervised classification places each detected MUP into a MUP 
train based on a certainty measure. In addition to using shape information the expected firing 
behaviour of MUs are estimated and used to determine if a candidate MUP belongs to a MUP train.  
In this way MUPs with similar shapes but created by different MUs can be differentiated by 
comparing their respective patterns of occurrence. MUPs classified as belonging to the same train that 
exceed a certainty threshold are averaged to form the MUP template for that train. It is this template 
that is measured to extract features representative of that MUP train.  
 
2.1.2 Interference Pattern Assessment 
EMG signals detected from a muscle during moderate to high levels of contraction are composed of 
large numbers of MUPTs that are superimposed. As such, an EMG signal is also known as an 
Interference Pattern (IP). The density and amplitude of an IP can be used to estimate MU recruitment 
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and firing rates. There are two computer-aided methods for analyzing an IP: frequency and time 
domain analysis [8].  
Frequency Domain Analysis 
The power spectrum of an IP can be used to infer features from the MUPs that comprise the IP. 
MUPs detected from myopathic MUs tend to be complex, have short durations and fast rise times as 
compared to MUPs indicative of normal MUPs. This will be reflected in the power spectrum as 
higher frequency components. MUPs detected from neuropathic MUs tend to have long durations and 
slow rise times as compared to MUPs indicative of normal MUPs. This will be reflected in the power 
spectrum as lower frequency components. The specificity and sensitivity of frequency domain 
analysis is poorer than time domain analysis because of the higher variability of an IP’s frequency 
spectrum. 
Time Domain Analysis 
Time domain analysis is based on the number of local peaks and valleys and the amplitude between 
successive peaks of opposite polarity. A peak is a turn if the amplitude to the next peak of opposite 
polarity exceeds a threshold of 25 or 50 µV. The amplitude of a turn is the difference in voltage 
between successive peaks of opposite polarity. One method of turns analysis considers the ratio of the 
number of turns (NT) to the mean amplitude (MA) of all of the turns. In general, a high NT/MA ratio 
is indicative of myopathy and a low ratio is indicative of neuropathy. Figure 2.1 provides a diagram 




Figure  2.1 Time Domain Analysis of an IP Signal 
A letter T with a number refers to a turn.  A letter S with a number refers to a segment of the IP that 
occurs between two successive turns. A letter A with a number refers to the amplitude of a segment. 
So as an example, A1 is the amplitude of S1, i.e. the segment from turn 1 (T1) to turn 2 (T2). Mean 
amplitude (MA) is calculated across all segments and NT is the total number of turns. (From SD 
Nandedkar, DB Sanders, EV Stalberg: Simulation and analysis of the electromyographic interference 
pattern in normal muscle. Part II: Activity, upper centile amplitude, and number of small segments.  
Muscle Nerve. 1986 Jul-Aug;9(6):486-90).  
2.1.3 Motor Unit Number Estimation 
Neuropathic disorders can decrease the number of motor units in muscles. An estimate of the number 
of motor units in a muscle suspected of a neuropathic disorder can be useful in tracking the progress 
of a disorder and or effectiveness of its treatment. A pair of EMG signals, one detected using a 
surface electrode and the other using an intramuscular needle electrode, are used together to estimate 
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the number of motor units in a muscle. A motor nerve bundle is electrically stimulated with sufficient 
intensity to ensure all motor neurons leading to the muscle under test are depolarized.  The surface 
EMG signal detected above the muscle under test is called a Compound Muscle Action Potential 
(CMAP). MUPs detected in the intramuscular needle EMG signal underneath the surface electrode 
are classified into separate trains where each train is believed to be detected from the same motor 
unit.  The set of firings of intramuscular detected MUPs belonging to the same train are used as 
triggers for locating intervals in the surface-detected signal. The set of intervals are ensemble 
averaged to extract the surface MUP (SMUP) corresponding to the intramuscular MUP train. The 
peak-to-peak amplitude of each SMUP is calculated. The average peak-to-peak amplitude is 
determined across all of the SMUPs. The number of motor units in the muscle under test is estimated 
by dividing the peak-to-peak amplitude of the CMAP signal by the average peak-to-peak amplitude 
of the SMUPs [7]. 
 
2.1.4 Muscle Fiber Jitter 
Jitter is measured by using the action potential of one muscle fiber as a reference and measuring the 
variability in time of the action potential of a second muscle fiber from the same motor unit [9]. 
Increased jitter is a clinical sign of a defective neuromuscular junction (NMJ). In a normal NMJ, there 
is an excess of acetylcholine (ACh) in the pre-synaptic terminal that can bind with numerous healthy 
post-synaptic ACh receptors leading to a depolarization of the muscle fiber. A defective NMJ occurs 
when either ACh or healthy ACh receptors are lacking leading to increased variability in time 
required to bind sufficient ACh to the post-synaptic membrane in sufficient quantities to depolarize 
the muscle fiber. In some cases, the number of ACh bindings is insufficient to cause a depolarization 
to occur at all thus blocking is said to occur.   
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     Increased jitter is often a sign of myasthenia gravis - a disorder that affects NMJs. Myasthenia 
gravis is caused by circulating antibodies that inhibit ACh receptors in the post-synaptic membrane 
from binding with ACh. 
2.1.5 Comparison of the QEMG Techniques 
Isolated MUP analysis can provide direct information about MU size, MU fiber density, the 
performance of neuromuscular junctions, the temporal dispersion of muscle fiber action potentials 
and MU firing behaviour. Time domain based IP EMG analysis can provide indirect information 
about the size of MUs.  IP QEMG can be useful for examining disease processes that affect MUs that 
are active only at higher levels of force since isolated MUP analysis becomes more difficult at higher 
levels of contraction. However for most disease processes isolated MUP QEMG provides a more 
comprehensive set of MU features [8].  
Motor Unit Number Estimation (MUNE) is useful when a neuropathic disorder is known or 
suspected to evaluate the extent of MU loss and to determine the effectiveness of treatments. MUNE 
is not likely to be used for an initial electrophysiological examination if the state of a patient’s 
neuromuscular systems is unknown, i.e. normal, myopathic or neuropathic or if the specific muscles 
affected in a patient are unknown. 
Analysis of jitter is only useful for diseases affecting the NMJ.  
2.2 MUP and Neuromuscular Characterization 
Section 2.1 gave an overview of QEMG techniques. This section provides further background for the 
MUP analysis method (2.1.1) used as the basis for the development and analysis of the CDSS which 
is the focus of this thesis. This work will use statistics generated by decomposition based MUP 
analysis, specifically features associated with MUP size and shape and use these feature values for the 
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characterization of MUPs. Other QEMG methods can be included in future work as sources of 
additional information for determining an overall muscle characterization. 
In general, QEMG decomposition based examination can be thought of as having three phases: 1) 
Data Acquisition, 2) Information Extraction: measurements and statistics determined from the data 
and 3) Interpretation: interpreting the information to reach conclusions. The interpretation phase can 
be thought of as having three steps: a) characterization of individual MUPs; b) integration of 
individual MUP characterizations into a muscle characterization and c) inference by a clinician as to 
whether a disorder is affecting the muscle or not, and if so, the type of disorder (myopathic or 
neuropathic) and its level of involvement. In contrast to the qualitative interpretation currently used in 
QEMG examinations, quantitative interpretation can facilitate the objective measurement of the 
degree of involvement of a neuromuscular disorder. This work addresses steps 3 a) and b) of the 
interpretation phase by describing and evaluating characterization processes that provide quantitative 
interpretation of information commonly extracted from individual MUPs during a QEMG 
examination. 
2.2.1 Existing MUP Characterization Techniques 
This work uses automated interpretation of quantitative shape-based isolated MUP features for the 
characterization of a muscle.   Methods in the literature for the characterization of individual MUPs, 
i.e. step 3 a) of the interpretation phase of a QEMG examination, are described in this section. 
Typically, the literature discusses how feature values for a set of MUPs detected from a single muscle 
can be combined into a muscle characterization using just three categories: myopathic, normal or 
neuropathic. These three categories provide an initial step towards a useful, robust neuromuscular 
CDSS. 
The literature describes a number of different processes for characterizing MUPs. Pattichis et al. 
[10] applied artificial neural network (ANN) models to the classification of MUPs sampled from the 
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biceps brachii muscle of 14 normal patients, 16 neuropathic and 14 myopathic patients. The data was 
divided into 24 training sets and 20 test sets. For each set, the means and standard deviations of 7 
features (duration, spike duration, amplitude, area, spike area, number of phases and number of turns) 
of the MUPs belonging to each muscle were determined. An error rate of 10 to 20% was achieved 
depending on the specific ANN architecture used. For instance, the ANN architecture that had 40 
neurons in the first hidden layer and 10 neurons in the second hidden layer achieved an error rate of 
10%. The authors found that ANNs easily tended towards over-fitting i.e., it was difficult to achieve 
generalization, the ability of the ANN to correctly classify unknown cases based on the training data. 
ANN models are not transparent because they do not reveal how they reach their conclusions. The 
large number of neurons means that a large number of arithmetic operations are used to transform the 
features making ANNs essentially black box classifiers. 
Pfeiffer and Kunze [1, 11] used Fisher’s Linear Discriminant Analysis (LDA) to determine the 
probability of the abnormality of each MUP (i.e. MUP characterization). The technique estimated the 
conditional probabilities (one for each category) of a MUP being detected from a muscle with a given 
category of disorder.   
In [1, 11], the discriminant model was trained based on 363 MUPs from 15 normal muscles, 467 
MUPs from 16 myopathic muscles and 463 MUPs from 23 neuropathic muscles using duration, area, 
turns count and center frequency as the features. The error rates using a single MUP for muscle 
characterization were 52.9% for myopathic disorders, 44.2% for neuropathic disorders and 35.2% for 
normal muscles with sample sizes of 1676, 714 and 2636 MUPs respectively. According to Pfeiffer & 
Kunze [1, 11], the high error rate could have been reduced if samples acquired during periods, 2 years 
apart were done in a more consistent manner. 
The method developed by Pfeiffer and Kunze determines a numeric probability of a MUP being 
detected from a normal, myopathic and neuropathic muscle. This allows a set of MUPs sampled from 
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a muscle to be quantitatively turned into a neuromuscular characterization. Despite the sampling 
problems experienced during testing, LDA is a successful method for MUP characterization. 
However, because of the arithmetic transformation of the features, LDA is not as transparent as 
classifiers that provide logical relationships between the features. 
2.2.2 Existing Muscle Characterization Techniques 
This section summarizes methods found in the literature describing how information across a set of 
MUPs detected from a muscle under test can be combined into a characterization of that muscle, i.e. 
step 3 b) of the interpretation phase of a QEMG examination.  There are two main methods for 
combining MUP statistics into a muscle characterization: means/outlier analysis and probabilistic 
methods. The means/outlier method is done by comparing the mean of a set of MUP feature values 
that are below or above normative limits and or by counting the number of outliers [12, 13]. 
Probabilistic methods were first introduced by Pfeiffer [1] who used Bayes’ rule to characterize 
muscles by combining for each MUP detected their conditional probabilities of being detected in a 
healthy muscle or one with a specific disorder. Analysis of individual MUP feature values lacks 
sufficient information to accurately characterize a muscle so Bayesian aggregation provides a 
statistically robust method for combining the feature values of several MUPs acquired from a muscle. 
Stewart et al. developed and evaluated a computer based system for acquiring MUPs, measuring 
their features and inferring a diagnosis (or characterization) [13] called the Means method. The mean 
and standard deviations of amplitude, area and thickness (area-to-amplitude ratio) values for sets of 
MUPs acquired from 68 normal subjects (18 - 62 years old) were calculated. The percentage of 
polyphasic and polyturn MUPs detected from these subjects was calculated as well. The normal range 
was defined as mean +/- 2 standard deviations. The method classifies a muscle as myopathic if one or 
more of the mean feature values falls below the normal range and classifies the muscle as neuropathic 
if one or more of the features falls above the normal range. The method was tested with MUPs 
 
 19 
detected from 50 patients with known myopathic and 55 patients with known neuropathic disorders. 
The error rate for characterizing patients as being affected by myopathic muscles was 44% and the 
neuropathic error rate was 36.7%.   
Stalberg et al. developed the Outlier method for characterization of muscles [12]. The goal of the 
method was to increase accuracy and reduce the number of MUPs that needed to be collected during a 
qualitative EMG examination. The method uses either extremely low or high feature values of MUPs, 
i.e. outliers to determine abnormality. The method uses the 5th and 95th percentiles of the third 
smallest and third highest set of values per feature collected from muscles to establish the low and 
high outlier threshold values. A muscle under test is declared myopathic if it has three or more low 
outliers of the same feature value or neuropathic if it has three or more high outliers of the same 
feature value.   
2.3 Generic Requirements for Clinical Decision Support Systems (CDSS) 
The following requirements are based on ideas developed by Kononenko [14] and Sprogar et al. [15] 
who describe a set of requirements needed for machine learning systems used in medical decision 
support. These requirements were used to guide the development and evaluation of the muscle CDSS 
described in this work. 
1) Transparent: Characterizations need to be presented in a manner that allows a clinician to 
understand how a characterization was determined. This is especially important when faced with an 
unexpected characterization that contradicts a physician’s initial expectation or intuition. A 
physician’s knowledge of the basis of a characterization is critical to the confidence in its veracity. A 
system’s ability to explain its characterizations or output is an important part of a physician’s 
acceptance of the system [16]. According to Feng [17] transparency to users requires that a 
characterization system provide logical versus arithmetic expressions of the features. Operators such 
as “and”, “or” and “if-then” are preferred to provide connections between feature values used to 
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explain classifications. These expressions are valuable since they provide meaningful explanations to 
human experts and are more easily evaluated.  
2) Accurate: Characterizations need to maximize both specificity and sensitivity beyond what is 
typically achieved through routine subjective analysis of an EMG signal.  This is essential if the 
approach is to be considered useful by clinicians.  
3) Report Confidence: A confidence measure reports the degree to which a characterization 
suggested by a classifier is likely to match the ‘true’ underlying characterization. It is intended to help 
clinicians minimize errors. A confidence measure is meant to minimize the number of situations 
where a characterization system makes a correct suggestion but is ignored by a physician. A 
confidence measure can also help avoid situations where a physician accepts an incorrect suggestion 
made by a characterization system if he/she over-trusts the characterization.  
4) Numeric Characterization Value: Characterizations need to be presented as numeric measures 
supporting or refuting each category under consideration, e.g. probabilities. The numeric scale can be 
ordinal but it is preferably that it has continuous values. A numeric MUP characterization will allow a 
method to combine individual MUP characterizations into an overall neuromuscular characterization.  
5) Mixed Mode Multi-Variate Features and Interdependency: Analyzing a single feature of a 
MUP has poor discriminatory power because of the wide range of values for any one MUP feature 
and the substantial overlap in the distributions of MUP features reflective of normal versus a diseased 
neuromuscular system [18]. Discriminatory power can be increased when multiple feature values are 
considered simultaneously [19]. For instance, a MUP with high amplitude only provides evidence that 
it was detected from a neuropathic muscle if it also has long duration.  
MUP characterization must be able to handle various mixed mode multi-variate data types that 
include numeric, Boolean, nominal and or ordinal. Numeric data can be continuous or discrete. 
Nominal data values are non-numeric, descriptive or use categorical labels. For instance the patient is 
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“normal” is an example of nominal data. Ordinal data values define a position or rank. For instance 
the patient “is weak” is an example of ordinal data. The system needs to handle any underlying joint 
probability distribution of the features used for characterization. A classifier needs to capture 
dependencies among the features. Clinical patterns that offer important clues to the type of a 
neuromuscular disorder often combine different data types. For instance, proximal muscles (nominal) 
affected by weakness (ordinal via MRC strength scale) with little or no wasting (ordinal) are often an 
indication of a myopathy [20] (nominal). Nominal data types provide a means of capturing more data 
relevant to the examination. In cases where there is a great deal of imprecision or subjectivity, a 
nominal description can provide useful additional information. For instance, the grading of strength 
on the MRC scale of 0 to 5 can be augmented with a description such as the smoothness (or lack 
thereof) of the contraction.  
6) Generalization: A MUP characterization system needs to accurately classify novel patterns that 
have not appeared in the training data. Classifiers that have been ‘tuned’ to the training data (i.e. over-
fitting) can achieve low error rates based on testing of the training data. However, they are unlikely to 
perform well for MUPs that have not been seen before or were not included in the training data [19].  
7) Handle Missing Data. A MUP characterization system needs to be able to handle missing feature 
values both in the training data and in the data extracted from the muscle under consideration without 
adversely affecting the outcome of a characterization. 
2.4 Possible Classification Methods 
Methods to characterize a neuromuscular system and to measure the degree of involvement of a 
disorder require a MUP characterization process that is accurate, allows the basis of it decisions to be 
easily understood, produces a numeric value in support of or refutation of a characterization, and is 
able to achieve generalization. Existing MUP and muscle Characterization techniques do not 
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completely satisfy these important requirements. It is hypothesized, that a classifier using pattern 
recognition techniques can meet these requirements. This section discusses the suitability of various 
classification methods based on the requirements in Section 2. 3.  
2.4.1  1st Order Logic 
A rule in first order logic is a sentence that is composed of quantifiers, variables, constants and 
functions that are connected with logical operators. A knowledge domain can be built up by asserting 
a set of rules that are known to be true. A query can be asked of the knowledge domain and a first 
order logic system will return true, false or unknown for a given query. Measurements that are 
continuous random variables must be converted to logic symbols using quantization techniques. In 
general it is difficult for a classifier based on 1st order logic to calculate probabilities. Therefore these 
systems are not suitable for the CDSS under consideration. 
KANDID [21] is an example of a decision support system that uses first order logic whose 
acronym stands for Knowledge-based Assistant for Neuromuscular DIsorder Diagnosis. It is used to 
plan and manage nerve conduction studies as well as diagnosis and reporting of neuromuscular 
disorders. 
2.4.2 Bayesian Networks  
A Bayesian network is a directed graph where each node represents a feature. Sets of arrows connect 
pairs of nodes where an arrow from node 1X to node 2X  means that 1X  is a parent of 2X . Each 
node stores a table of conditional probabilities where the parent nodes are the given features of a 
conditional probability.  The conditional probability table associated with a node provides the effect 
of the state of the parents on the probability outcome of the node. A Bayesian network can provide an 
estimate of the joint probability density function for a classification problem. The joint probability of 
a set of feature values occurring is given by the notation ( )nn vXvXvXP === ,,, 2211 K  where 
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ii vX =  means that feature iX has taken on the value iv . A probability prediction for 
( )nvvvP ,,, 21 K can be calculated as follows [22]: 







21 |,,, K   (2.1) 
where ( )iXparents  represents the values of the features of parent nodes of node iX  
An example of a muscle disorder decision support system based on Bayesian Networks is called 
MUNIN [23]. MUNIN stands for MUscle & Nerve Inference Network. There are four layers in its 
Bayesian Network leading from the underlying disorders to the findings. At the top layer are the 
muscular disorders. The second layer is the impacts of the disorders on the physiology of a muscle. 
The third layer is the impact on the physiology of a muscle as well. Layers two and three are both 
required for physiological factors in the event that more than one disorder is present at one time. The 
last layer represents the findings as determined by clinical tests, instruments, and doctor examination 
or patient reports. The major limitation of MUNIN is that it requires human medical expertise in 
determining the conditional probability tables. Machine learning techniques can be applied to learn 
the optimal structure of a Bayesian network from training data, however, the problem is considered 
intractable because of the large space of possible network structures to be searched [22, 24]. 
Machine learning is more efficient for Naïve Bayesian Networks. A Naïve Bayesian (NB) 
classifier is built by assuming that all of the features are conditionally independent of each other. A 
NB classifier is rather simplified in that it doesn’t reveal any interdependencies among the features. 
The NB classifier produces a score 
ks for each category by taking the product of the conditional 
probabilities of each feature whose value falls within a pre-defined interval [19].  The scores are 
normalized resulting in a set of conditional probabilities that sum to 1.  It is a discrete classifier since 
it handles nominal and discrete data types and requires continuous features to be quantized. A NB 
 
 24 
classifier cannot uncover the underlying distribution of the data nor easily provide a transparent 
explanation. Therefore a naïve Bayesian network is unlikely to uncover the underlying distribution of 
the data as well as a full network. NB classifiers can be augmented so that they provide some 
transparency by reporting the individual contribution of each feature towards the probability that an 
observation belongs to a category [25]. 
 
2.4.3 Decision Trees 
A decision tree (DT) is a structure of tests done on the feature values of a test instance that leads to a 
classification. Each node in a tree specifies a test to be made on a single feature. The first node of the 
tree is known as the root node. Each branch coming out of the node is labeled with the outcome of the 
test applied at the node. When a leaf of the tree is reached the value specified by the leaf, i.e. the 
category is returned as the result to a query made using feature values. It can handle discrete features, 
Boolean, nominal and ordinal. Continuous features need to be quantized. A DT can produce a 
conditional probability estimate of the category given a test instance. Specific high order interactions 
are difficult to uncover because a decision tree is built by considering one feature at a time. DTs can 
be augmented so that rules can be extracted by tracing the path taken through the tree. Since a single 
feature at a time is tested this does not readily reveal relationships among the features [26].  
There are a number of algorithms that will build decision trees based on labeled training data. 
One of the most popular is Quinlan’s [27] ID3 algorithm for constructing decision trees. The 
discriminatory power of a feature can be determined by calculating the entropy [19] of the various 
categories that match the feature value that the emerging branch of the node represents. Entropy 
provided by a node can be thought as the impurity across all of the branches emerging from a node 
where each branch represents a specific feature value – higher entropy corresponds to higher levels of 
impurity.  In a two category system impurity in a branch is the ratio of the number of instances of 
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training data of the category with the greatest number of instances over all instances of data appearing 
in that branch. So if each branch had only instances of training data belonging to a single category 
then each branch would have zero impurities, i.e. zero entropy. Therefore a feature where each branch 
has no impurities would contribute high classification accuracy to a DT.   The process for inducing a 
decision tree from training data starts by calculating the impurity for each feature. The feature with 
the lowest level of impurity is chosen to be the first test in the tree since it has the highest 
classification accuracy. This algorithm is applied iteratively to the other features until the leaves of 
the tree are reached. 
The C4.5 algorithm is an extension to ID3 that adds abilities such as handling missing data, 
pruning of decision trees, rule derivation and the quantization of feature value ranges [19]. These 
improvements lead to decision trees that are smaller and often achieve higher classification accuracy. 
Decision trees can provide a conditional probability estimate of a category given a set of feature 
values by counting the number of instances of a category that appear in a leaf node. In general, 
decision trees provide poor probability estimates for two reasons [28]. First, decision tree induction 
methods try to make leaves homogeneous so observed probabilities in leaves are biased towards zero 
or one. Second, the estimates have high variance because often the numbers of training examples in a 
leaf are small leading to observed frequencies that are not statistically reliable. 
A decision tree does not give insight into the relationship among features [26]. Specific high 
order interactions are difficult to uncover because a decision tree is built by splitting one variable at a 
time.  
Physicians typically agree that the first node in a decision tree is the most important question 
[14]. The first node in a tree induced from training data may not reflect the most important diagnostic 
question because a feature is chosen based on reducing node impurity. Also a pruned tree does not 
allow a physician to look at the contribution of all of the features in making a diagnosis.   
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2.4.4 Artificial Neural Networks 
A popular tool in pattern recognition is the artificial neural network (ANN). Inspired by an 
understanding of the human brain an artificial neuron is composed of input links, input function, an 
activation function and an output [22]. A single layer of neurons can be arranged to provide a single 
linear decision boundary.  Multiple layers of neurons can be arranged to provide multiple linear 
decision boundaries and can be used to represent a wide range of decision functions.  ANNs are not 
totally transparent in that they cannot easily provide an explanation for their conclusions that are 
directly understood.  
2.4.5 Fisher’s Linear Discriminant Analysis  
Fisher’s Linear Discriminant Analysis (LDA) is an approach that selects a set of features 
associated to each category, that can maximally distinguish among different categories or classes i.e. 
maximize the ratio of  (variance between categories) / ( variance within categories) [29]. The 
coefficients of the functions are unit vectors that maximize the above ratio. The number of 
discriminant functions is:  min (#classes-1, #parameters). So with K number of classes there are (K-1) 
number of discriminant functions, unless the number of features is less than (K-1). Discriminant 
functions rotate and scale the training data to maximize the distance between categories. Each 
instance in a set of training data can be transformed into a set of discriminant coordinates using the 
learned discriminant functions.  The center of a category can be estimated by calculating the mean of 
the discriminate coordinates of a set of training data. The distance to the category centroid is used to 
estimate whether a test instance belongs to a specific category or not. An example of two discriminant 
functions called D1 and D2 with three features F1-3 are shown below. 
 
D1 = v11*F1 + v21*F2 + v31*F3 (2.2) 




vij is the coefficient for the i
th feature for the jth discriminant function 
 
The coefficients vij are determined by maximizing the covariance between the categories in the 
training data over the covariance within the categories. This is subject to the condition that the 







  (2.4) 
 
B is the between categories covariance matrix and W is the within categories covariance matrix. The 
B & W matrices can be calculated from the training data. Taking the first derivative of the above 
equation with respect to v and solving leads to the solution of v.  
Pfeiffer and Kunze [1, 11] applied LDA to characterize MUPs by calculating the probability that 
a particular MUP was detected from a myopathic, normal, or neuropathic muscle.  Each MUP in the 
training data is mapped to a set of discriminant coordinates ( )21 , DD  by applying the discriminant 
functions to the feature values of the MUPs. Test MUPs are classified by finding the Euclidean 
distance to the centroid of the set of discriminant coordinates in the training data of each category. 
The test MUP is classified to the category whose centroid has the minimum distance to the test MUP.  
2.4.6 Pattern Discovery 
Information-theory based statistical inference can be used for the detection of significant patterns. 
Wong and Wang [30-33] describe the use of information theory based pattern discovery (PD) for 
classification. Their classification algorithm is composed of three parts: discovery of significant 
patterns, rule selection and classification.  
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A significant pattern is said to occur when a set of feature values occurs together more often than 
expected assuming a random occurrence.  For continuous data, a range of feature values is quantized 
into a natural language label as is used in the clinic: e.g. small, medium or large. A statistical test of 
significance determines if a significant pattern has occurred. Patterns that include a category label can 
be used as rules for classification. The order of a rule is determined by the number of features, 
including the category label, found in a pattern. An example of a 4th order rule is a MUP 1:labeled 
myopathic  with 2: low amplitude, 3: low duration and 4: high number of turns. 
An information theoretic measure called weight of evidence (WOE) represents the discriminatory 
power of a rule. A rule may be statistically significant but the WOE is needed to determine if the rule 
provides negative, neutral or positive evidence to refute or support a classification. A large negative 
WOE score means that the category suggested by the rule is highly unlikely to occur. A large positive 
WOE score means that the category suggested by the rule is highly likely to occur. Rules with WOE 
scores near zero neither support nor refute the likelihood of the classification. Section 4.1 will discuss 
this technique in more detail. 
The rules used for classifying an observation are selected starting with the highest order rule first 
and accumulating its WOE. The features used in the highest order rule are then excluded and the rule 
with an equal or lower order is found and its WOE is added to the total. This process is continued 
until no more rules are found or all of the features have been considered. PD is a flexible 
classification system because a prediction of a category can be made on any subset of the features 
describing an observation. The system can also classify new observations that have missing data.   
It is  hypothesized that a PD classifier can meet most of the requirements discussed in Section 2.3 
because it has the following advantages over existing classification methods: a) able to discover 
multivariate rules comprised of mixed mode features, b) transparent because it can reveal the 
significant patterns, discovered as a set of feature values, which contributed most significantly to the 
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classification, c) the ability to handle any underlying probability density and d) the ability to classify 
new observations that have missing data. It can easily handle discrete features. For instance 
observations made by a physician about a patient’s symptoms are often discrete, unordered (nominal) 





MUP Features, MUP Data and Performance Measures 
This chapter defines the features measured from MUP templates and describes the different MUP 
data sets used in this work. The MUP data sets are organized by the type of decomposition system 
used to establish MUP templates either DQEMG or Multi-MUP. The chapter ends by defining the 
type of measures used to evaluate the performance of different characterization systems.  
3.1 Definition of MUP Features 
The following definitions are from [34] unless otherwise noted. Refer to Figure 3.1 for a graphical 
depiction of many of the features defined below. 
Duration (ms) is defined as the time between starting point (onset) and end-point of a MUP. These 
points are often determined by deviation from the baseline and exceeding a minimum slope criterion. 
The onset and end markers defined by automatic algorithms need to be inspected manually by a 
human operator and sometimes may need to be reset.  
Spike duration (ms)  is defined as the time between the first and last positive peaks of the MUP.  
Amplitude (µV) of a MUP is the difference in voltage from the maximal negative to the maximal 
positive peak within the duration of a MUP.  
Area (µV·ms) is calculated from the rectified MUP signal within the duration.  
Thickness (ms) is defined by area-to-amplitude ratio (AAR) [35].  
Size Index is a logarithmic function of thickness and amplitude that is related to the size and shape of 
a MUP [36, 37].  
A phase is the part of a MUP that falls between baseline crossings and exceeds a minimal amplitude 
threshold. The number of phases is counted within the duration.  
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A turn is a local peak, either negative or positive in the MUP waveform. Peaks generated by noise are 
excluded by defining a turn as a peak that exceeds a minimum voltage change between successive 
peaks. 
 
Figure  3.1 MUP Feature Depictions (From D.W. Stashuk, T.J. Doherty: "Normal Motor 
Unit Action Potential" in Neuromuscular Function and Disease , vol. 1, W. F. Brown, C. F. 
Bolton and M. J. Aminoff, Eds. Philadelphia, PA: Elsevier Science, 2002, pp. 291-310.) 
3.2 DQEMG Decomposed MUP Data 
MUP data described in this Section were estimated by decomposing EMG signals using DQEMG [7]. 
DQEMG typically finds 51 isolated MUPs produced by a single motor unit, aligns them using 
maximum slope, and uses a median trimmed average to form the MUP template. DQEMG uses a 25 
µV threshold to define a turn and a phase has to have amplitude of at least 20 µV and duration of at 
least 240 µs. A revised Size Index (rSI) was used for MUP data decomposed by DQEMG and was 
calculated by ( )( ) ( )( )msmV thicknessamprSI 1010 log8.1log ⋅+=  [37]. 
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3.2.1 Simulated Data 
EMG signals were simulated using a physiologically-based model [38] to help examine the 
relationship between level of involvement and MUP characterization performance. The simulator was 
extended to also allow simulation of the affects of neuropathic and myopathic disorders [39].   To 
simulate a neuropathy, motor units are reorganized progressing from random motor neuron death to 
random re-innervation of orphaned fibers by nearby surviving motor neurons. To simulate 
inflammatory myopathy, a small percentage of randomly selected healthy fibers are “infected” and 
atrophied by a small fraction, and a smaller proportion are hypertrophied by a small fraction. This 
process is iterated by infecting additional fibers, and atrophying and hypertrophying the newly and 
previously infected fibers until the prescribed level of involvement is reached. A fiber is considered 
non-functioning (i.e. dead) when its diameter is below a critical threshold.  
The simulator models the recruitment of motor units necessary to bring the level of force 
produced by a diseased muscle up to a prescribed percentage of the maximal voluntary contraction 
(MVC) force of a healthy muscle. Therefore, a simulated muscle that is normal, or with 25% or 75% 
motor unit loss at 10% MVC are each modeled as if producing close to the same force. EMG signals 
detected using a concentric needle at various intramuscular positions of several different muscles 
during approximately 7 to 10% MVC contractions were simulated and then decomposed into MUP 
templates.  This method mimics the completion of several EMG studies across different individuals 
and includes levels of background MUP interference and noise typical of clinical studies. A 
comparison done by Hamilton-Wright and Stashuk [38] of the quantitative analysis of simulated 
versus real healthy decomposed MUPs shows good correspondence. 
In total, 500 MUPs were extracted from simulated EMG signals of normal muscle, 500 from 
myopathic muscle and 500 from neuropathic muscle. The myopathic/neuropathic MUPs, in 
approximately equal proportion, were simulated to come from muscles with 25%, 50% and 75% 
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muscle-fiber/motor-unit loss. Each MUP was labeled as either normal, myopathic or neuropathic 
allowing comparison with the literature that use these labels [1, 10, 11] .   
3.2.2 London Health Sciences (LHS) MUP Data 
Control and neuropathic MUPs were sampled from the biceps-brachii and first dorsal interosseous 
(FDI) muscles.  In total, 1649 MUPs from 54 muscles were sampled from 16 healthy control subjects 
(aged 27 ± 4 years) and 427 MUPs from 22 muscles were sampled from 14 patients, including 9 
patients (aged 52 ± 12 years) with clinically probable or definite amyotrophic lateral sclerosis as 
defined by the revised El Escorial criteria [40] and 5 patients (aged 37 ± 11 years) with Charcot-
Marie-Tooth Disease Type 1X confirmed via genetic testing. 
A disposable concentric needle electrode (Model N53153; Teca Corp., Hawthorne, NY) was used 
to acquire EMG signals during 30 s voluntary isometric contractions performed at between 10% and 
20% of each individual subjects’ maximal voluntary contraction using DQEMG on a Neuroscan 
Comperio (Neuroscan Medical Systems, El Paso, Texas) with a bandpass of 10 Hz–10 kHz at a 
sampling rate of 31.2 kHz as previously described [41-43].   
3.2.3 Rigshospitalet (Rigs) Data 
A standard concentric needle electrode was used to acquire EMG signals for 11.2 seconds during 
voluntary contraction of various muscles and then amplified by a high impedance differential 
amplifier (DISA, 15C01) and analog band-pass filtered with high and low pass filters set at 2 Hz and 
10 kHz. The EMG signals were sampled and digitized at a sampling frequency of 23437.5 Hz with 16 
bit resolution (Motorola DSP56ADC16). 
MUP data was acquired from biceps muscles to establish control data. MUP data was acquired 
from primarily biceps and vastus medialis muscles from patients with different types of myopathy 
(various forms of dystrophy, polymyositis and unknown myopathies) and ALS. MUP data was also 
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acquired from FDI, APB (Abductor pollicis brevis), and TA (Tibialis Anterior) muscles of patients. 
More information about this data is available in [44]. 
3.3 Multi-MUP Decomposed MUP Data 
The data described in this section was obtained by decomposing EMG signals using the multi-MUP 
technique described previously [45, 46] where many different individual MUPs, detected at a single 
needle insertion point, that are deemed to belong to the same MUP train by a shape based classifier 
are averaged. The mean and SD of time points of the set of MUPs are calculated. The MUP template 
is calculated by excluding points that lie outside the ±1 SD in the time point average. The Multi-MUP 
system has many similarities with DQEMG. However, a drawback of the Multi-MUP system is its 
inability to capture MUPs with long risetimes according to Miki Nikolic who has had extensive lab 
experience with the system [44].  Another difference between Multi-MUP and DQEMG is the 50 µV 
[45] threshold for defining a turn compared to the 25 µV threshold used by DQEMG. Multi-MUP 
also defines size index (SI) as ( ) ( )msmV thicknessampSI +⋅= )(10log2  [36]. 
3.3.1 University of Ljubljana External Anal Sphincter (EAS) MUP Data 
Quantitative MUP data from a group of 86 (58 men) patients [46] (Podnar, et al. 2002) (called patient-
sensitivity) was used to study sensitivity. Data from a group of 77 (49 female) control subjects [47] 
(Podnar. 2004) (called control-specificity) was used to study specificity, and data from a separate 
group of control subjects sampled from 64 control subjects [46] (Podnar, et al. 2002) (called control-
reference) was used to establish normative thresholds. The patients had cauda equina or conus 
medullaris lesion. The control-specificity group consisted of subjects referred for minor pelvic floor 
dysfunction but whose examination showed no neuromuscular or other related disorders. The 
normative thresholds of the control-reference data were set at +/- 2 SD for the means and at the 5th-
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95th percentiles for outliers and were previously published [46] (Podnar, et al. 2002). The diagnosis of 
the subjects and patients was made as per standard clinical practice reported previously [45, 47-49].  
Intramuscular EMG signals were detected using a concentric needle electrode and a commercial 
EMG system (Keypoint; Alpine Biomed Neurodiagnostics, Skovlunde, Denmark) with a bandpass of 
5 Hz–10 kHz as previously described [50] (Podnar and Vodusek. 1999). Using the multi-MUP 
technique described previously (Podnar, et al. 2002, Stålberg, et al. 1995) individual MUP waveforms 
were estimated and their feature values calculated [46].  
 
3.3.2 University of Ljubljana Biceps MUP Data 
EMG signals were acquired from 33 biceps muscles of healthy subjects and 30 biceps muscles from 
patients with a genetic diagnosis of facioscapulohumeral muscular dystrophy (FSHD) using a 
standard concentric EMG needle, and a commercially available EMG system (Keypoint; Medtronic 
Functional Diagnostics, Skovlunde, Denmark) with standard settings (filters: 5 Hz to 10 kHz) [51]. 
Sampling of a muscle continued until at least 20 different MUPs per muscle were decomposed using 
multi-MUP analysis. 
3.4 Distribution of MUP Thickness Feature among Categories 
The distribution of MUP thickness values for each category for the data used in this thesis was 
estimated using a Parzen window technique using a Gaussian kernel.  The distributions were used to 
represent the separation of the data across the different categories to gauge the difficulty in accurately 
characterizing the data. Categories that are more separated should be easier to characterize accurately 
than categories that are less separated.  Thickness was chosen as the feature to represent separation 
because it is thought to be highly discriminative [35, 52]. Other features showed similar distributions 
per category and data set.  
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Figures 3.2 and 3.3 show the estimated distributions of thickness for the simulated and Rigs data 
respectively. They show that myopathic data has the lowest mean thickness followed by normal and 
then neuropathic data. This is expected because myopathic data tends to have the thinnest MUPs 
followed by thicker normal and then neuropathic MUPs. Figure 3.2 shows that the variance of 
myopathic and neuropathic data is larger than that of normal which is expected. Figure 3.4 and 3.5 
show the estimated distributions of thickness for the LHS and EAS data respectively where the 
normal category has a lower mean and variance than the neuropathic category.   
The mean  and standard deviation of thickness values for the Rigs, LHS, and the Ljubljana biceps 
data (LJUB-Biceps) shown in Table 3.1 are similar for respective categories.  The mean and standard 
deviation of thickness values for the Rigs data compared to the LHS data shown in Table 3.1 are 
slightly different.  
All of the data sets have a great deal of overlap in the distributions of thickness values among the 
different categories as expected according to [18] but there is some separation in the data among the 
categories. However, the EAS data does not have a great deal of separation between its categories as 
shown by how closely the distributions align in Figure 3.5 and the small distance value of the EAS 
data compared to the other data sets as shown in Table 3.1. All of the other data sets have more 
separation between categories than compared to the EAS data. The LHS and Ljubljana-biceps data 
had very similar distances while the Rigs data had the greatest separation of all the MUP data sets as 
shown in Table 3.1. It is expected that the EAS data will have lower characterization accuracy and the 
Rigs data set will have higher characterization accuracy than the other MUP data sets based on 













Figure  3.2 Estimated Distribution of Thickness - Simulated Data 
 
 



















Figure  3.4 Estimated Distribution of Thickness - LHS Data 
 












Table  3.1 Mean, Standard Deviation and Distance of Thickness Distributions 
DATA mean SD mean SD mean SD Distance
SIM 0.91 0.35 1.03 0.20 1.23 0.27 0.38
RIGS 1.06 0.54 1.41 0.55 2.36 1.25 0.52
LHS 1.36 0.48 1.82 0.58 0.43
EAS 0.85 0.37 0.94 0.46 0.11
LJUB-Bicep 1.03 0.45 1.40 0.45 0.42
MYO NORM NEUR
 
The distance shown in the last column in Table 3.1 for the two-category distributions was calculated 
by ( ) ( )2121 σσ +−= mmD  where im is the mean for category i and iσ was the standard deviation 
of category i. Distance for the three-category distributions was calculated by taking the average across 
all combinations of two-category distances.  
 
3.5 Performance Measures 
When analyzing the EAS, LHS and Ljubljana biceps data that had only two categories, sensitivity 
and specificity were the terms used to describe per category accuracy. Sensitivity for the EAS and 
LHS data was defined as the total number of muscles characterized as neuropathic divided by the 
total number of ‘true’ neuropathic, i.e. patient muscles. Sensitivity for the Ljubljana biceps data was 
defined as the total number of muscles characterized as myopathic divided by the total number of 
‘true’ myopathic, i.e. patient muscles. Specificity was defined as the total number of muscles 
characterized as normal divided by the total number of ‘true’ normal, control muscles. Accuracy was 
defined as the average of sensitivity and specificity. The traditional definition of accuracy (true 
negatives + true positives)/(all muscles tested) was not used because it is biased towards the category 
that has the largest number of test muscles to be characterized. The traditional accuracy measure 
would be skewed by an unequal proportion of controls to patients. For instance, the traditional 




The term sensitivity-specificity deviation (SSD) was defined as: 
( ) 2/)()( 22 SpecASensASSD −+−=   (3.1) 
where  A  is accuracy - the mean of specificity and sensitivity. 
Sens  is sensitivity, and  
Spec  is specificity,  
For data sets with three categories, i.e. Rigs and simulated data, overall accuracy A was the mean 
across per-category accuracies, i.e. kA  is the accuracy for category ky  – the number of observations 
of category ky  that were classified as ky divided by the total number of observations with ‘true’ 
category ky . The SSD for three categories is then:  
( ) 3/)()()( 222 neurnormmyo AAAAAASSD −+−+−=  (3.2) 
where  myoA , normA and neurA are the accuracies for the myopathic, normal and neuropathic categories 
respectively. 








MUP Characterization  
This chapter describes the Pattern Discovery method in detail and then applies it for the 
characterization of MUPs. The PD method was evaluated and compared to other pattern recognition 
techniques using the criteria for a CDSS described in Section 2.3.  
4.1 Pattern Discovery Based Classification.  
A MUP can be characterized using Pattern Discovery (PD) by discovering rules in a set of training 
data. Further information about this PD method can be found in [30-32, 53]. Given a training data set 
with N MUP samples, a MUP X  is described by M features },,{ 1 Mxx L=X  where each feature 
Mixi ≤≤1  is a random variable. Each feature can take on a value from its discrete alphabet 
},,{ 1 imiii ααα K=  where im is the number of characters in the alphabet of the i
th feature. A primary 
event occurs when a single feature ix takes on a value from iα . The p
th primary event is denoted by 
][ piix α=  or simplified to ipx . 
rX is an rth order event that contains r primary events. A set of 
category labels },,,{ ,1 Kk yyy LL contains K  labels and Kk ≤≤1 . The number of features, 
including a category label, determines the order of an event.  An example of a 4th order event would 
be a MUP from a neuropathic muscle, i.e. labeled neuropathic, with high amplitude, high duration 
and a high number of turns. For continuous data, the range of feature values can be divided into pre-
defined intervals, i.e. quantized, and each interval labeled in a natural language as is often used in the 
clinic: e.g. small, medium, or large. If the number of observations (denoted by sXo ) of an event is 
significantly higher or lower than the number of expected observations (denoted by sXe ) assuming 
randomly distributed data then an event is said to be a pattern when it passes a test of statistical 
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significance using the adjusted residual sXd [30] and the number of expected observations exceeds a 











XNe α  (4.1) 
where N is the number of MUPs and NoX
ipx
p
ii == )Pr( α  
Equation 4.1 calculates the expected number of observations based on the NULL hypothesis that the 
feature values comprising an event are independent. An event is called a pattern when the NULL 
hypothesis is rejected by testing using adjusted residual. The adjusted residual is calculated by first 











=   (4.2) 
The standardized residual is considered to have a Gaussian distribution when the asymptotic variance 
of s
X
z is close to one, otherwise the standardized residual has to be adjusted to a Gaussian 










d =    (4.3) 
where s
X
v is the maximum likelihood estimate of the variance of s
X
z  
A positive pattern occurs if 96.1>s
X
d at 95% confidence level. 
A negative pattern occurs if 96.1−<s
X
d at 95% confidence level. 
If the pattern contains a category label then it is a rule. Because they contain category labels and are 
significant based on a statistical test, rules can be used for characterization. The discriminatory power 
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of the lth  thr order rule, rlX , can be determined by its weight of evidence (WOE), which is the odds 
of a sample MUP,  which has a subset of feature values that match the feature values of  rlX , 















=   (4.4) 
where: 
MUP = ky ,  MUP is detected in a muscle of category ky  . 
MUP ≠ ky ,  MUP is detected in a muscle not of category ky .  
P(X | Y)  the probability of X occurring given that Y has occurred – a conditional probability. 
r
lX    an 
thr order pattern, where l  is an index indicating the lth, rth order pattern. 
Note that the range of (4.4) is +∞<<∞− WOE .  A rule labeled ky  with positive WOE provides 
support for the category ky .  A rule supporting a label other than ky will have a negative WOE and 
provides refutation for the category ky . The strength of the support (or refutation) is proportional to 
the absolute value of the WOE.  An thr  order rule where Mr <  is called a component rule. The 
union of disjoint component rules of the same category, i.e. the union of the set of component rules 
with no overlapping features, discovered in a MUP is called a compound rule and is denoted by *kx .  
There is one compound rule per category per MUP and the category is denoted by the subscript k 
in *kx . 
The weight of evidence for a category for a MUP under test is the sum of the WOEs of each 
component rule that belongs to the compound rule associated with the MUP under test.  The total 
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WOE provides either support or refutation of category ky . The PD classifier calculates K weights of 
evidence (one for each category) for each MUP under test.  
 
4.2 Evaluation of MUP Characterization Methods 
The performance of several classifiers used to characterize the simulated MUP data (Section 3.2.1) 
and LHS MUP data (Section 3.2.2) were evaluated. 
4.2.1 Other Classifiers Considered for MUP Characterization 
The classification performance of three other classifiers was compared with the PD classifier: two 
discrete classifiers – Weka J48 DT and Weka NB; and one continuous – LDA. Although not as 
transparent as the other classifiers, LDA was chosen for comparison because it was previously used 
for MUP classification [1, 11]. DT and NB classifiers were chosen because they are commonly used 
in medical decision support, are regarded as being transparent [14, 26], and can handle nominal data. 
The DT and NB classification error rates were determined using the algorithms of the Weka explorer 
system [24]. A Matlab function, RAFisher2CDA [54], was modified to calculate the Fisher 
discriminants used for LDA classification.   
4.2.2 Training and Testing  
Thirty trials were conducted using the PD, LDA, DT, and NB classifiers with the simulated MUP data 
partitioned into different sets of training and test data. There was a complete separation of training 
and test data for each trial. Three hundred samples from each category were randomly chosen for 
training per trial for a total of 900 training samples. Each trial used the same training and test data for 
the different classification methods. After the training data was chosen, the remaining data was used 
to test the classifiers to establish classification performance. A mean classification error rate and 
standard deviation was calculated to determine classifier performance. This process was repeated for 
 
 45 
the LHS MUP data except the LHS data consists of two categories and so 600 training samples per 
trial were used.  
The classifiers used the following MUP features: amplitude, duration, phases, turns and thickness 
otherwise known as area-to-amplitude ratio (AAR). Except for LDA, which requires continuous data, 
the MUP data was quantized into intervals before being used for classification. The discrete 
classifiers (PD, DT and NB) were all presented with the same quantized training and testing data sets. 
This prevented NB and DT from using their own quantization methods so that the effects of 
quantization on classification accuracy were not a factor in the comparison. Using only three intervals 
keeps the number of rules and the size of the decision tree to a reasonable size; and features can be 
easily translated into linguistic labels such as low, medium, and high which is conceptually consistent 
with clinical practice. As well, three intervals help to simplify the visual patterns that explain the 
results leading to diagrams that are easily recognized and understood by clinicians. The natural 
logarithm of amplitude was taken before determining the linear discriminant functions to minimize its 
skewness. Prior to quantization none of the features were transformed for PD, DT, and NB 
classification. 
The classification error rate of using a single MUP to characterize a muscle was examined. The 
per category error rate was defined as the number of MUPs that incorrectly predicted the muscle 
category divided by the total number of MUPs detected from muscles of that category. 
 
4.3 Results LHS MUP Data 
PD had an average error rate (and standard deviation) of 30.3% (1.8%), LDA 29.0% (2.1%), DT 
30.1% (2.1%) and NB 29.8% (1.8%) across thirty trials. All four characterization methods had similar 
error rates with no statistically significant differences between each other according to the Tukey post 
hoc test at a significance level of 0.05. Table 4.1 shows NB had the highest sensitivity and LDA had 
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the highest specificity and accuracy. However, PD had a significantly lower SSD compared to the 
other methods. J48 had the next best SSD, which was about 2 times the SSD of the PD method.  
4.4 Results Simulated MUP Data 
PD had an average error rate (and standard deviation) of 24.3% (1.2%), LDA 23.1% (1.4%), DT 
24.6% (1.2%) and NB 27.0% (1.4%) across thirty trials. A Tukey post hoc test showed that LDA had 
a significant improvement at the 0.05 level compared to the other classifiers. PD and DT did not have 
statistically significant differences between each other according to the Tukey post hoc test at a 
significance level of 0.05. The Tukey post hoc test between the other classifiers and NB showed that 
it had a significant decrease in performance at the 0.05 level.  
Tables 4.2 and 4.3 show the confusion matrix for PD and LDA simulated MUP data 
classifications respectively. The confusion matrices shown were determined as an average of the 
confusion matrices across the thirty trials. The Tables show that the per category error rates for 
simulated normal and neuropathic are similar with a dramatic improvement for simulated myopathic 
data. 
 If only normal and neuropathic simulated MUP data error rates are compared, Table 4.2 shows 
an average error rate across two categories of 29% for the PD classifier and Table 3 shows a two 
category error rate of 28.8% for the LDA classifier, which are very similar to the error rates of the 
LHS data of 30.3% and 29.0% respectively. Note that the LHS data did not include any myopathic 
data.  
Figure 4.1 shows that as the level of simulated involvement increased, the classification error rate 
decreased for MUPs detected from simulated myopathic and neuropathic muscles. Neuropathic 
MUPs had error rates of 48%, 30%, and 21% for levels of involvement of 25%, 50%, and 75% 
respectively. Myopathic MUPs had error rates of 22%, 13%, and 7% for levels of involvement of 
25%, 50% and 75% respectively.  
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Table  4.1 Sensitivity/Specificity and Accuracy of Characterization of LHS MUP Data 
Sensitivity Specificity Accuracy SSD
PD 71.7% 67.8% 69.7% 1.9%
LDA 65.8% 76.2% 71.0% 5.2%
J48 66.3% 73.5% 69.9% 3.6%
NB 75.7% 64.8% 70.2% 5.4%  
 
The results in Table 4.1 are the mean sensitivity, specificity, and accuracy across thirty trials for the LHS MUP 
data. The SSD is based on the means shown in Table 4.1. The training data for each trial consisted of three 
hundred randomly chosen samples from each category for a total of 600 samples. After the training data was 
chosen, the remaining data was used to test the classifiers to establish classification performance. Each trial 
used the same training and test data across the different classification methods. 
 
Table  4.2  Pattern Discovery Confusion Matrix (simulated MUP data) 
True Class Myopathic Normal Neuropathic per class error rate
Myopathic 170 20 10 15%
Normal 20 144 36 28%




The PD confusion matrix shows that myopathic simulated MUPs had the lowest per-category classification 
error rate of 15%. The neuropathic MUPs had the highest per-category error rate at 30%. This confusion matrix 
shows the expected per-category distribution of errors. The probability of error that a MUP detected from a 
myopathic muscle is misclassified as normal is 2 times greater than being misclassified as neuropathic (20/200 
versus 10/200). A similar trend appears for neuropathic data where the probability of error of a MUP being 





Table  4.3 LDA Confusion Matrix (simulated MUP data) 
True Class Myopathic Normal Neuropathic
per class 
error rate
Myopathic 176 20 4 12%
Normal 17 138 45 31%





The LDA confusion matrix shows that there was an increase in the error rate for normal classifications from 
28% to 31% and a decrease in error rate from 30% to 27% for neuropathic classifications compared to the PD 
classifier. The confusion matrix for LDA shows the expected distribution for incorrectly classified MUPs 
detected from muscles with disorders is 5 times greater for normal than myopathic and about 2.5 times greater 

























4.5 Discussion MUP Characterization 
Table 4.4 summarizes a comparison of the studied classifiers for four of the identified requirements 
based on the study results and consideration of the known properties of each classifier. PD has an 
advantage with respect to transparency. All four methods have similar accuracy. PD, DT and NB can 
handle mixed mode data types while LDA cannot because of its inability to handle nominal data. All 
four classifiers can produce a numeric value for characterization.  In addition, while the 
computational effort required for training for each method can be significant, it is done offline prior to 
clinical use and only needs to be done once. The computational effort for characterization expended 
by each method is similar and not consequentially different from current QEMG examinations. 
Figures 4.2 to 4.4 are example PD characterizations of three different LHS MUPs and Figure 4.5 
is an example characterization of a simulated MUP. The reporting of the component rules that support 
each characterization demonstrates the transparency of PD characterization. Furthermore, the rules 
discovered by PD are consistent with currently used diagnostic criteria [34, 35, 55, 56] (see Table 
4.5).  These MUP characterizations demonstrate that the PD classifier is capable of capturing 
knowledge consistent with current practice and expressing it in transparent, understandable terms. 
The knowledge is captured while simultaneously considering multiple feature values and expressed 
using common clinical terminology. 
PD characterization provides a transparent explanation of the set of features weighted by their 
contribution, using both negative and positive rules that refute or support characterization towards the 
various categories. The system is able to objectively calculate the WOE that a MUP was detected 
from a normal or neuropathic muscle. This reduces the mental workload of the clinician, which 
should reduce the number of errors in both individual MUP characterizations as well as overall 
muscle characterizations. This leads to the expectation that examining clinicians will make fewer 
errors.   
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The error rate of the LDA and PD method based on normal and neuropathic LHS MUP data is 
about 25% lower than the error rate achieved in Pfeiffer’s work [1].  Pfeiffer’s data [1], collected two 
years apart, was not done consistently. It is not expected that PD will achieve better accuracy than 
LDA. If PD were tested using the data set in [1] performance similar to LDA would be expected. 
PD’s advantage however is transparency.  
DT, NB and PD based classifiers are suitable for use in MUP characterization; however, PD has 
an advantage over DT and NB based on its transparency. The low error rate of the LDA method helps 
to confirm Pfeiffer’s conclusion that LDA classification is an accurate method [1]. However, LDA is 
not very transparent and cannot easily handle nominal data types – an important requirement in 
extending a clinical decision support system to handle other clinical observations. DT classifiers use 
an error reduction based training algorithm and therefore provide rules that are used to minimize 
classification error. This can lead to over-fitting problems. NB and DT methods, as mentioned 
previously, cannot find relationships among multiple features. PD rules are determined through 
observation of statistically significant relationships in the training data without considering 
classification accuracy and capture the dependencies among features using hypothesis testing. 
Although accuracy across the four methods did not differ significantly for the LHS MUP data, PD 
had a significant advantage in its ability to maximize both sensitivity and specificity.  A clinic with 
unknown “costs” for false negative and false positive characterizations would favour a 
characterization method that maximized both sensitivity and specificity.  
The characterization methods had similar error rates for LHS MUP data, and simulated normal 
and neuropathic MUPs. This suggests that the simulator can be useful for studying the relationships 
between level of involvement and characterization performance for normal and neuropathic MUPs. 
However, the lower error rates achieved by the LDA and PD methods for simulated myopathic versus 
neuropathic data may be an artifact of the simulator. The simulator does not deal with changing 
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muscle density or structure.  A separate study using clinical data from both inflammatory and non-
inflammatory myopathic disorders is needed. Overall the error rate for the simulated MUP data was 
lower than the LHS MUP data because of the excellent performance of the simulated myopathic data. 
The similar performance of the methods for characterizing normal and neuropathic categories is 
consistent with the similarity in distance between the distribution of thickness values for the normal 
and neuropathic categories of the LHS and simulated MUP data as discussed in Section 3.4. If only 
the normal and neuropathic categories of the simulated MUP data were compared to the LHS data 
then the distance between these categories was 0.43 for both the simulated and LHS MUP data 
calculated using data from Table 3.1.   
Although the results shown by Figure 4.1 are for simulated MUP data, they are consistent with 
the expectation that as a disease affects a greater portion of a muscle the probability of detecting 
MUPs that reflect the effects of the disorder increases thus reducing the number of errors made when 
categorizing MUPs detected from muscles with higher levels of involvement of a disorder. On the 
other hand, the reduced probability of detecting a MUP that reflects the affects of a disorder on a 
muscle during the early stages of involvement suggest that further development of QEMG methods, 
to combine MUP characterizations and/or use other QEMG based features, is needed to improve both 
the specificity and sensitivity with which a muscle can be characterized.  Chapter 5 studies two 




Table  4.4  Summary of Classifiers' Fit to Requirements 
Requirement PD LDA DT NB 
Transparency ∗∗∗∗  ∗∗  ∗∗∗  ∗∗∗  
Accuracy ∗∗∗  ∗∗∗  ∗∗∗  ∗∗∗  
Mixed –Mode Data ∗∗∗∗  ∗∗  ∗∗∗∗  ∗∗∗∗  
Numeric Characterization ∗∗∗∗  ∗∗∗∗  ∗∗∗∗  ∗∗∗∗  
 
Number of stars: Four – excellent, three – good, two – fair, one – poor. Accuracy ratings are based on the error 
rate discussed in the results. Transparency is based on the classifier’s ability to report strength of 
support/refutation of a subset of features. Ability to handle mixed mode data and produce a numeric 
characterization scores are based on examining the methodology of the classifiers. 
 
4.5.1 Conclusions  
Unlike the other classifiers investigated, the PD classifier is able to explain itself by reporting the 
sets of feature values, along with a strength-of-evidence measure, supporting or refuting its 
characterizations.  This work has demonstrated that the PD classifier meets the requirements for 
normal and neuropathic MUP characterization through its abilities to report its characterizations in a 
transparent manner, handle mixed mode data, discover dependencies among features, provide 
numerical characterization values, and achieve a similar level of characterization accuracy as state of 
the art classification methods. The PD classifier shows promise as a clinically useful method of 
providing numerical inputs to the next step of the interpretation phase of a QEMG examination 
(muscle characterization based on more than one MUP).  
The PD classifier succeeds in interpreting the information extracted from quantitative MUP 
analysis and transforming it into knowledge that is consistent with current clinical practice. This 
demonstrates that the transparency provided by the PD classifier can be valuable for the capture and 
expression of knowledge useful to a clinician. 
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Characterization of the LHS and simulated, normal and neuropathic, MUP data had very similar 
error rates. These results provide encouragement to develop and evaluate a PD method for 
quantifying the level of involvement of a neuromuscular disorder – ultimately fulfilling one of the 
roles for future QEMG examinations envisioned by Swash [57]. 
Chapter 5 will focus on evaluating methods that combine MUP characterizations obtained using 




Figure  4.2 Evidence Supporting Characterization of LHS MUP 1352 as normal. 
 
The upper lefts of Figures 4.2-4.5 show MUP templates each of which is the median-trimmed average 
of 51 isolated MUP firings deemed by DQEMG to belong to the same MUP train. Each of the MUP 
templates is displayed using the same scale. The y scale is in microvolts and the x scale is 
milliseconds. The upper right box of each Figure shows the result of quantization of the five MUP 
features into a low, medium or high quantization interval along with their continuous values prior to 
quantization. For instance in Figure 4.2 MUP 1352 is quantized as follows: thickness (AAR) of 1.35 
is medium, 2 turns are low, 2 phases are low, duration of 10.2 ms is medium and amplitude of 353 µV 
is medium. The next two bar plots underneath show the component rules providing evidence for or 
against the MUP being detected from a normal or neuropathic muscle respectively. Features 
belonging to the same component rule are indicated by using the same line style (e.g. solid, dashed, 
dotted etc.). A component rule is positive if the bars go to the right from the vertical line and a 
component rule is negative if the bars are left of the vertical. The x-axis for a negative rule is also 
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marked with a negative sign for low, medium and high to emphasize that these are rules refuting the 
characterization. 
The bar graph marked as ‘Patterns Supporting Normal’ shows that all of the features formed a 
single component rule since they are all solid leading to a WOE of 1.58 that MUP 1352 was detected 
from a normal muscle. The bar graph marked as ‘Patterns Supporting Neuropathic’ shows a single 
component rule for neuropathy. The component rule indicated by the solid line refuting neuropathic is 
composed of medium thickness (AAR), and low turns and has a WOE of -1.49.  Since the WOE for 




Figure  4.3 Evidence Supporting Characterization of LHS MUP 1676 as Normal. 
The bar graph in Figure 4.3 titled as ‘Patterns Supporting Normal’ shows two component rules 
making up a compound rule for normal – one rule as a solid line, the other as a dashed line. The 
component rule indicated by the solid line supporting normal is composed of low thickness (AAR), 
low turns, low phases and high amplitude. The other component rule indicated by a dashed line is 
composed of high duration and refutes normal with a WOE of -1.21.  In the ‘Patterns Supporting 
Neuropathic’ bar graph there are two component rules. The component rule indicated by the solid line 
with low thickness (AAR), low turns, and low phases has a negative WOE of -2.22. The other 
component rule indicated by a dashed line is composed of high duration and has a WOE of 1.21.  In 
total, the WOE for being detected from a normal muscle is less than one at 0.28, and from a 
neuropathic muscle -1.02. The spread between the highest WOE and the second highest WOE for 
MUP 1676 is 1.3. This indicates a slightly lower level of confidence towards a classification for 





Figure  4.4 Evidence Supporting Characterization of LHS MUP 1584 as Neuropathic. 
The bar graph in Figure 4.4 titled as ‘Patterns Supporting Neuropathic’ shows a compound rule 
comprised of two component rules that provide evidence that MUP 1584 was detected from a 
neuropathic muscle. A component rule (dashed line) of high amplitude provides a WOE of 1.05 and a 
component rule (solid line) of high thickness (AAR), high turns, low phases, and high duration 
provides a WOE of 1.28. In total, the two component rules provide WOE of 2.33 that this MUP was 





Figure  4.5 Evidence Supporting Characterization of Simulated MUP 1676 as Myopathic 
The bar graph in Figure 4.5 titled as ‘Patterns Supporting Myopathic’ shows that the WOE of the first 
component rule indicated by a solid line of low thickness (AAR), high turns, high phases and low 
duration plus the WOE from the second component rule (dashed line) of low amplitude provides a 
total WOE of 5.24 that MUP 522 was detected from a myopathic muscle. The compound rules 
supporting normal and neuropathic both have a large spread (10.26 and 8.16 respectively) below the 










Table  4.5  Current Clinical Criteria for MUP Characterization 
# Rule Description Indication of Source 
1 decreased duration, decreased amplitude, polyphasic myopathy [56] 
2 decreased AAR myopathy [35] 
3 increased duration, increased amplitude, polyphasic neuropathy [56] 
4 increased amplitude (and/or area) with normal or increased AAR neuropathy [35] 
5 increased amplitude, high number of turns, may not be polyphasic neuropathy [34] 
 
LHS MUP 1352 (Figure 4.2) with medium duration and amplitude, low number of turns, low phases and 
medium thickness (AAR) was characterized by the PD classifier as being normal. LHS MUP 1584 (Figure 4.4) 
with high duration and amplitude, low phases and high turns and high thickness (AAR) was characterized by 
the PD classifier as being neuropathic agreeing with rules 4 and 5. Simulated MUP 522 (Figure 4.5) with low 
duration and amplitude, high numbers of turns and phases and low thickness (AAR) was characterized by PD as 













Muscle Characterization  
Individual MUP characterizations lack sufficient information to accurately characterize a muscle; as 
such, multiple MUP characterizations need to be combined to provide an accurate muscle 
characterization. In this chapter we examine two methods for calculating muscle characterization 
measures: arithmetic mean and Bayes’ rule.  Given a set of MUPs detected from a muscle under 
examination, the information provided by each MUP can be combined into a Probabilistic muscle 
characterization. An example of a probabilistic muscle characterization is a 79% probability the 
muscle is neuropathic and a 21% probability the muscle is normal given the set of MUP 
characterizations based on the MUPs detected from that particular muscle.   
5.1 Estimating MUP Conditional Probabilities   
A muscle under test can be characterized by combining the set of characterizations of the MUPs 
detected from it. Consider that the clinical state of a muscle can be assigned to one of K specific 
categories with labels },,,{ ,1 Kk yyy LL  (i.e. myopathic, normal, or neuropathic). In this work, the 
characterization of a MUP is defined by a set of K MUP conditional probabilities, one for each 
category. Each MUP conditional probability )|( MUPyP k  measures the probability of category yk 
given the detected MUP. Therefore a MUP characterization can be expressed as a set of conditional 
probabilities ( ) ( ){ }
iKi MUPyPMUPyP ||1 K . 
5.1.1 Compound Rule Conditional Probability for PD 
The WOE that PD produces needs to be expressed as a conditional probability to obtain a muscle 
characterization.  This conditional probability is called the Compound Rule Conditional Probability 
(CRCP). The CRCP [52, 58, 59] is an estimate of the conditional probability that MUPi was detected 
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in a muscle of category ky  given the occurrence of the feature values associated with the compound 































xMUPyMUPP  (5.1) 
where:  
ki yMUP = ,  iMUP  was detected in a muscle of category ky  (i.e. a normal or neuropathic 
muscle). 
*
kx   Compound rule associated with category ky . 
*
kxMUP = ,  MUP feature values that match the compound rule 
*
kx  (i.e. a set of quantized 
feature values)  
WOE  Weight of Evidence of the compound rule *kx  supporting or refuting 
category ky . 
)(0 kyP  ,  prior probability of category ky . 
Equation 5.1 is derived in Appendix A.  
The conditional probability of category ky given detected MUPi can be estimated using the 





















|    (5.2) 
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Table 5.1 provides example component rules for estimating ( )ik MUPyP |  assuming that the features 
amplitude, duration, area, thickness, and size index are used for characterizing a MUP using two 
categories: normal or neuropathic. In this example, each of the feature values are quantized into one 
of five intervals called very low, low, medium, high, and very high. Also, a prior probability of 0.5 is 
assumed for each category. A MUP with very high amplitude, low duration, very high area, low 
thickness, and high size index is compared against the rules that were created by the training data. 
Two component rules are found for the normal category and two component rules are found for the 
neuropathic category and are shown in Table 5.1. The WOE for a component rule is calculated by 
counting the number of instances in the training data that match the rule’s category and counting the 
number of MUPs in the training data that do not match the rule’s category to empirically determine 
the probabilities of belonging to that category and not belonging to that category. For instance, the 
first rule in Table 5.1 has 200 MUPs with very high amplitude and low thickness labeled neuropathic 
and 100 MUPs with very high amplitude and low thickness labeled normal in training data that has 



























The compound rule that refutes the normal category has a WOE of -3.7 (found by summing the two 
component rules for normal). Note that the WOE refutes normal because it is negative. Using 
equation 5.1 the CRCP for normal for this MUP is 0.0714. The compound rule that supports the 
neuropathic category has a WOE of 1.61 with a CRCP of 0.75325. Using Equation 5.2 to normalize 
the Compound Rule Conditional Probabilities to add to 1 results in a MUP Characterization of 
P(Normal | MUP) = 0.08 and P(Neuropathic | MUP) = 0.92. 
Further details of the Pattern Discovery based method for MUP characterization [52, 58, 59] are 




Table  5.1 Example Rules for Calculating a MUP Characterization 
Component Rule Category WOE 
Very high amplitude and low thickness Normal -1 
Low duration and very high area Normal -2.7 
Very high amplitude and very high area Neuropathic 2.61 
Low thickness and high size index Neuropathic -1 
  
 
5.1.2 LDA Based MUP Characterization 
Probability estimates of MUP features under test were found by assuming that the feature values 
were Gaussian distributed [1, 11]. LDA Minimum Euclidean Distance (MED) assumes that each 
category has equal covariance and calculates the conditional probability of each category given a test 
iMUP  ( ( )ik MUPyP |  ) by finding the Euclidean distance of the discriminant coordinates of the test 
MUP to the centroid of the set of discriminant coordinates in the training data of each category and 
then calculating the probability assuming Gaussian distribution.  
5.2 Muscle Characterization Methods 
Probabilistic muscle characterization was compared to conventional muscle characterization methods.  
5.2.1 Probabilistic Muscle Characterization  
Two probabilistic methods for combining MUP characterizations were evaluated in this chapter: 





Arithmetic Mean Muscle Characterization 
The arithmetic mean characterization measure calculated for a muscle category was done by 
taking the arithmetic mean of the set of MUP characterizations of that category and is called 











)(  (5.3) 
where for Equations 5.3 & 5.4: 
ky     muscle category, i.e. myopathic, normal or neuropathic. 
( )ik MUPyP |  the MUP characterization value for category ky  of the 
th
i MUP 
detected from the muscle under test. 
N     Number of MUPs detected from the muscle under test. 
Bayes’ Rule Muscle Characterization 
In previous work Pfeiffer used Bayes’ rule to combine MUP characterizations into a muscle 
characterization that consisted of a conditional probability that a muscle belonged to a particular 
category (i.e., neuropathic vs. myopathic) given the set of MUP characterizations [1]. A Bayes’ rule 
muscle characterization measure calculated for a muscle category is done using Bayes’ rule for 
multiple pieces of evidence, where each piece of evidence is a MUP characterization of that category 
and assuming each MUP characterization is conditionally independent of each other [1, 19, 52]. This 
is called Bayes’-rule Muscle Characterization (BMC) and is calculated by 
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Equation 5.4 assumes that the prior probabilities used are the same for each category to obtain an 
unbiased muscle characterization that is based solely on the electrophysiological evidence provided 
by the detected MUPs. The author believes that each MUP is adding independent information except 
in those cases where more than one MUP is detected from the same MU. The derivation for Equation 




Product of MUP 
Characterizations
Muscle Characterization
Set of MUP Characterizations
P(muscle category | MUPi )






Figure  5.1 Bayes’ Rule Muscle Characterization (BMC) 
The pie charts on the left hand side show the characterizations of MUPs detected from the same 
muscle for a scenario with three muscle categories (myopathic, normal and neuropathic).  Each 
category is represented by a colour; medium grey is myopathic, light grey is normal and black is 
neuropathic. The proportion of a pie is the conditional probability of a category given a detected 
MUP, e.g. the upper left pie shows a MUP that has approximately 50% probability of being detected 
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from a myopathic muscle, a 20% probability of being detected from a normal muscle and 30% 
probability of being detected from a neuropathic muscle. The product of the conditional probabilities 
of the MUPs for each category was calculated and the probability of a muscle belonging to a category 
given the set of MUP characterizations is determined using Equation 5.4. The larger pie chart on the 
right hand side shows the muscle characterization given the set of MUPs, approximately 38% 
myopathic, 53% normal and 9% neuropathic in this example. 
 
5.2.2 Conventional Muscle Analysis: Means and Outlier Method 
Stewart et al. developed and evaluated a technique where, given a set of MUP features, a muscle 
category is determined by comparing the mean value of each MUP feature, calculated across MUPs 
detected from a muscle under examination, to its corresponding normative threshold values [13]. The 
Means method calculates the mean normative threshold value using all the MUPs sampled from 
control muscles from which greater than 15 MUPs were detected. Threshold values for each feature 
are calculated using sets of 15 or more MUPs detected from the corresponding muscle of a pool of 
control subjects. For each set of 15 or more MUPs the mean of the feature values is calculated 
resulting in a mean value per feature per muscle. The overall mean and the standard deviation of the 
means are then calculated for each feature across the set of mean values per muscle. (Note: the overall 
mean and the standard deviation of the means for each feature are obtained from the set of mean 
values of the control muscles and not across all MUPs.) The threshold values used for the Means 
method for each feature are defined as the overall mean ±2 standard deviations of the means.  For this 
work, muscles were categorized as myopathic when one or more mean feature value fell below a 
threshold value of the normative range and neuropathic when one or more mean feature value fell 
above the threshold value of the normative range. 
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Stalberg developed a method for categorizing a muscle by counting the number of outliers of 
each MUP feature from the set of the first 20 MUPs detected from a muscle under study [12]. A MUP 
feature value is considered an outlier if it is below or above the low and high outlier thresholds for 
that feature, respectively. The first 20 MUPs detected from each muscle in the pool of control 
subjects are used to determine outlier thresholds for each feature. Muscles with less than 20 detected 
MUPs are not used for establishing outlier thresholds. For each muscle and for each feature, the set of 
feature values of the first 20 MUPs is sorted in ascending order and the third lowest and the third 
highest value are added to a set of low and high outliers for that feature, respectively. The lower 
outlier threshold for a feature is the 5th percentile of the set of low outliers and the high outlier 
threshold is the 95th percentile of the set of high outliers. A muscle under examination for which there 
are three or more outlying MUP feature values of the same feature each below the lower outlier 
threshold is categorized myopathic. A muscle is categorized as neuropathic if three or more outlying 
MUP feature values of the same feature were above the higher outlier threshold.   
As an additional method for muscle categorization the Means and Outlier methods are combined 
as in [47] and called the Combined method.  If either the Means or Outlier method or both declares a 
myopathic/neuropathic abnormality, then the Combined method categorizes the muscle as 
myopathic/neuropathic. 
The Means, Outlier and the Combined methods are referred to as the conventional methods.  
 
5.3 EAS MUP Data  
The Bayes’ rule characterization method was used to analyze the EAS MUP data described in Section 
3.3.1 and compared to the performance of the conventional methods. PD and LDA MED were used to 
provide MUP characterizations for the Bayes’ rule method. BMC-PD refers to using Bayes’ rule 
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using PD based MUP characterizations and BMC-LDA refers to using Bayes’ rule using LDA MED 
based MUP characterizations. 
5.3.1 Training, Testing, Features 
EAS MUP Training 
Performance of the BMC and the conventional methods vary depending on the data used for 
training.  In this study, only control-reference data was used for training of the conventional methods, 
whereas control-reference and patient-sensitivity data was used for training of the BMC methods. 
Performance for all of the methods was determined across ten different trials using randomly chosen 
training data. The training data for a single trial of the conventional methods consisted of 116 control-
reference muscles for the Means method and 100 control-reference muscles for the Outlier method. 
The training data for the BMC methods used all of the MUPs, from all of the 126 control-reference 
muscles and an equal number of MUPs sampled from the patient-sensitivity data by randomly 
selecting muscles and using their MUPs for training resulting in a mean number of 134 muscles being 
drawn from the patient-sensitivity data across the 10 trials.  Table 5.2 summarizes the number of 
MUPs per muscle and the number of muscles used for training the various methods. 
Table  5.2 Number of MUPs and Muscles used for Training: EAS MUP Data 
Method 
Minimum 
# of MUPs 
per muscle 
# of MUPs in 
muscle used for 
training 
# control-reference 
muscles used for 
training * 
# patient-sensitivity 
muscles used for 
training * 
Mean 15 All 116 0 
Outlier 20 First 20 100 0 
Bayesian 1 All 126 134 
The Mean method calculates the Mean threshold value using all of the MUPs in muscles with greater 
than or equal to fifteen MUPs. The Outlier method uses the first twenty MUPs in muscles with 
 
 69 
greater than or equal to twenty MUPs to calculate the Outlier threshold. The BMC methods uses all of 
the MUPs in a muscle for training regardless of the number MUPs detected.  
*The fourth and fifth column of this Table refers to the number of control-reference and patient-
sensitivity muscles used for training in the ten trial scenario as described in Section 5.3.1. 
EAS MUP Testing 
Only muscles from the control-specificity and patient-sensitivity groups with greater than twenty 
MUPs were used for testing. For each trial, all of the 113 muscles with 20 or more MUPs from the 
control-specificity data were used to measure specificity and all of the muscles that did not have any 
MUPs selected for training from the patient-sensitivity group, mean of 57 muscles across the 10 trials, 
were used to measure the sensitivity. For each trial, the same set of test muscles was used across the 
conventional and BMC methods to ensure fair comparison. The number of true negatives and true 
positives from each test were accumulated to arrive at the overall specificity and sensitivity results for 
each of the methods.  
Values for the following MUP features were input to the different methods: amplitude, duration, 
area, number of phases, number of turns and spike duration [45, 48] as well as thickness otherwise 
known as area-to-amplitude ratio (AAR) [35] and size index (SI) [36]. All possible combinations of 
features taken two, three and four at a time were selected from the eight possible features to form 
feature sets. Each feature set was then used for evaluating the performance of the BMC-PD, BMC-
LDA and conventional methods as described above.  
5.3.2 EAS MUP Results 
Table 5.3 shows the mean sensitivity, specificity, accuracy, and SSD across all possible feature sets 
comprised of two, three or four features.  
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The conventional methods had lower mean accuracy and greater difference between sensitivity 
and specificity than the BMC methods as highlighted by the large SSD values of the conventional 
methods in Table 5.3. As the number of features used for characterization increased, sensitivity 
increased while specificity decreased for the conventional methods, e.g. for the Outlier method 
sensitivity increased from 33.5% to 47% and specificity decreased from 83.1% to 74.2% for two and 
four features per set respectively.  
With the BMC methods sensitivity and specificity were steadier than the conventional methods as 
the number of features used for characterization increased. The sensitivity for the BMC-LDA method 
increased by 1.3% and specificity for the BMC-LDA method increased by 0.2% with four features in 
a set as compared to two features in a set as shown in Table 5.3. The BMC-LDA method had a 
significant improvement in accuracy compared to the BMC-PD method according to a paired t-test 
across the feature sets in Table 5.3 at a significance level of 0.05. 
Table 5.4 shows the best five feature sets as sorted by accuracy for each method. The 
conventional methods favoured area, thickness, and turns as the most discriminative features, since 
they occur most frequently in the top five sets. The BMC–PD favoured thickness, size index, and 
turns and the BMC–LDA method favoured thickness, and turns as the most discriminative features 
because of how often they occurred in the top five feature sets. The top five features sets for the 
Means method had very poor sensitivity but high specificity leading to an SSD of about 20%. The 
combined method had the best sensitivity and accuracy of the conventional methods when looking at 
the five best feature sets in Table 5.4. The best sensitivity of the BMC methods was ten percent 
higher than the best sensitivity of the combined method. The best specificity of the combined method 
was four percent higher than the best specificity of the BMC methods when looking at the five best 
feature sets in Table 5.4. The top five features of the combined method had lower accuracy than the 
BMC–LDA and BMC–PD methods. 
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5.3.3 Robustness of Best Feature Sets 
To examine the effects of different clinics using different data for training, the best performing 
feature set of each method was selected for further analysis by executing 100 trials with a reduced 
number of control and patient muscles used for training and an increased number of patient muscles 
used for testing.   For the BMC methods, for each trial, muscles of the control-reference data set were 
randomly selected until approximately 75% of its MUPs were selected. An equal number of MUPs 
per trial were also randomly sampled from the patient-sensitivity data by random muscle selection. 
The mean number of muscles used for training the BMC methods across all of the trials was 95 from 
the control-specificity data and 101 from the patient-sensitivity data. For the conventional methods, 
for each trial, a subset of the control-reference muscles chosen for training the BMC methods that met 
the criteria as shown in the second column of Table 5.2 were selected to calculate the mean and 
outlier threshold values. The mean number of muscles used for training the Mean and the Outlier 
methods across all of the trials was 88 and 76 respectively from the control-reference data. The test 
data per trial was selected using muscles not used for training resulting in 113 muscles being tested in 
the control-specificity data and a mean of 83 muscles across the 100 trials for the patient-sensitivity 
data. 
Table 5.5 addresses the robustness of the methods by showing how performance varied for the 
best feature set of each method across a larger number of trials of different randomly chosen training 
data that was used to determine the results in Table 5.4. The results in Table 5.5 were determined 
using 100 trials and approximately 75% of the training data while Table 5.4 used 10 trials and 100% 
of the training data. For each feature set used, the standard deviation of sensitivity and specificity 
across the 100 trials is reported. Standard deviation across 100 trials does not appear to be 
significantly different than the SD shown in Table 5.4 for the best feature sets. Table 5.5 shows an 
expected reduction in accuracy because of the reduced amount of training data used compared to 
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Table 5.4. The difference in accuracy of Table 5.5 compared to Table 5.4  is shown in brackets for 




Table  5.3 Average Performance across All Possible Feature Combinations of EAS Data 
Mean SD Mean SD Mean SD
Sens. 29.2% 4.1% 35.1% 4.1% 39.2% 3.5%
Spec. 90.5% 2.9% 87.6% 2.8% 85.3% 2.7%
Acc. 59.9% 2.0% 61.4% 1.7% 62.2% 1.7%
SSD 30.6% 3.0% 26.2% 3.1% 23.1% 2.6%
Sens. 33.5% 7.4% 41.3% 6.8% 47.0% 6.3%
Spec. 83.1% 5.6% 78.0% 4.9% 74.2% 4.2%
Acc. 58.3% 1.9% 59.7% 1.6% 60.6% 1.5%
SSD 24.8% 6.3% 18.3% 5.7% 13.6% 5.1%
Sens. 41.3% 5.5% 49.6% 5.4% 55.2% 5.1%
Spec. 80.0% 5.5% 74.4% 4.9% 70.1% 4.2%
Acc. 60.7% 2.2% 62.0% 2.0% 62.6% 2.0%
SSD 19.3% 5.0% 12.4% 4.7% 7.7% 4.0%
Sens. 68.1% 5.3% 65.4% 4.6% 63.6% 5.2%
Spec. 57.2% 7.0% 61.4% 4.6% 61.6% 3.7%
Acc. 62.6% 2.6% 63.4% 1.9% 62.6% 2.4%
SSD 7.2% 4.2% 4.6% 2.5% 4.5% 1.6%
Sens. 65.3% 3.5% 66.0% 3.3% 66.6% 2.7%
Spec. 63.1% 4.1% 63.1% 2.8% 63.3% 2.2%
Acc. 64.2% 2.0% 64.5% 1.9% 64.9% 1.3%










BMC–PD represents Bayesian method using PD to estimate conditional MUP probabilities. 
BMC–LDA represents Bayesian method using LDA to estimate conditional MUP probabilities. 
The standard deviation (SD) is calculated across the different feature sets 
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Table  5.4 Five Most Accurate Feature Sets per Method: EAS MUP Data 












area/thick/phases 45.5% 5.3% 86.7% 0.0% 66.2% 2.7% 20.5% 2.7%
area/thick/turns 43.3% 5.6% 88.5% 0.0% 65.9% 2.8% 22.6% 2.8%
area/thick/SI/phases 44.7% 4.4% 86.7% 0.0% 65.7% 2.2% 21.0% 2.2%
area/thick/phases/turns 46.4% 4.9% 85.0% 0.0% 65.6% 2.5% 19.3% 2.5%
area/thick/turns/spike_dur 44.2% 3.7% 86.7% 0.0% 65.4% 1.8% 21.3% 1.8%
dur/area/phases/turns 53.2% 4.1% 75.2% 0.0% 64.2% 2.1% 11.0% 2.1%
area/thick/SI/turns 57.5% 4.6% 69.9% 0.0% 63.7% 2.3% 6.2% 2.3%
area/thick/turns 56.7% 5.0% 70.8% 0.0% 63.7% 2.5% 7.1% 2.5%
thick/SI/turns/spike_dur 57.5% 5.1% 69.9% 0.0% 63.7% 2.6% 6.2% 2.6%
area/thick/turns/spike_dur 57.4% 6.7% 69.9% 0.0% 63.7% 3.3% 6.2% 3.3%
dur/area/phases/turns 61.9% 4.2% 71.7% 0.0% 66.8% 2.1% 4.9% 2.1%
area/thick/phases/turns 63.9% 4.6% 69.0% 0.0% 66.5% 2.3% 2.9% 1.7%
area/thick/turns/spike_dur 63.9% 6.1% 69.0% 0.0% 66.5% 3.1% 3.2% 2.3%
area/thick/turns 62.1% 5.0% 70.8% 0.0% 66.4% 2.5% 4.5% 2.3%
thick/SI/turns/spike_dur 63.8% 3.6% 69.0% 0.0% 66.4% 1.8% 2.8% 1.5%
SI/phases/spike_dur 71.2% 5.9% 63.5% 4.0% 67.4% 2.0% 4.3% 4.1%
area/thick/phases/turns 68.1% 6.6% 66.5% 3.7% 67.3% 2.5% 3.8% 2.7%
thick/SI/phases/turns 69.1% 3.5% 65.5% 2.1% 67.3% 1.9% 2.0% 2.0%
area/thick/SI/turns 70.9% 5.9% 63.6% 3.2% 67.2% 3.8% 3.6% 2.8%
thick/SI/turns 72.0% 8.6% 61.4% 3.7% 66.7% 3.3% 7.1% 2.9%
thick/phases/turns 74.1% 2.7% 66.2% 1.7% 70.2% 1.5% 4.0% 1.8%
dur/turns 71.8% 6.4% 64.9% 1.8% 68.3% 2.8% 4.1% 2.9%
area/thick/SI/turns 70.3% 6.8% 65.5% 1.7% 67.8% 3.4% 3.4% 2.5%
thick/turns 67.8% 6.2% 67.8% 1.6% 67.8% 2.8% 2.8% 2.2%
area/thick/turns 70.2% 5.0% 65.2% 1.2% 67.7% 2.2% 2.6% 2.8%










Table  5.5 Performance of the Best Feature Sets Across 100 Trials: EAS MUP Data 












Mean area/thick/phases 45.5% 5.3% 86.6% 2.0% 66.0% 2.2% 20.6% 3.3%
Outlier dur/area/phases/turns 50.6% 4.5% 75.8% 2.0% 63.2% 2.0% 12.6% 2.8%
Combined dur/area/phases/turns 60.1% 4.0% 72.1% 1.9% 66.1% 1.9% 6.1% 2.4%
BMC-PD SI/phases/spike_dur 68.4% 5.6% 63.5% 4.5% 65.9% 2.0% 4.2% 3.2%





5.4 LHS MUP Data  
5.4.1 LHS  MUP Data Training, Testing, Features 
The LHS MUP data described in Section 3.2.2 was studied in this subsection. Performance for all 
of the methods was determined across ten different trials using randomly chosen training data. Only 
control muscles were selected for training the conventional methods, whereas muscles from both 
control and patient groups were used for training of the Probabilistic methods. Within a trial, all 
muscles were tested one at a time. All of the patient muscles, except the patient muscle under test, 
were used for training of the Probabilistic methods and the muscle under test was classified (or 
categorized) as being of the category with the maximum muscle characterization value.  A set of 
control muscles were selected at random until the number of MUPs in the patient training data 
equaled the number of MUPs from the control muscles. The set of control muscles used for training 
of the Means method and the control muscles used for training the Probabilistic method were the 
same per trial. All muscles in the control data had 20 or greater MUPs except one muscle that had 19 
MUPs.  The set of control muscles used for training the Outlier method was identical to that used for 
training the Means and Probabilistic methods with the exception of trials that included the muscle 
with 19 MUPs. It had to be excluded from the Outlier method training since it requires 20 or greater 
MUPs. .  
All muscles in the data were used for testing of the conventional and Probabilistic methods 
regardless of the number of MUPs detected per muscle. Values for the following QEMG-MUP 
features were input to each of the different methods: amplitude, duration, area, number of phases, 
number of turns [7]. In addition, thickness [35] and revised size index (rSI) [37] were also used as 
features. All possible combinations of feature sets taken two, three, four and five at a time were 
examined for sensitivity, specificity and accuracy to determine which combination of features used 
simultaneously is the best choice for a sensitive and specific muscle categorization. Each different 
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feature set was subjected to ten trials, where the set of training data used per trial was the same from 
feature set to feature set.  The sensitivity across 22 muscles and the specificity across 54 muscles 
were recorded for each trial.  Accuracy and SSD were then calculated for each trial. AMC-PD and 
BMC-PD refers to using the AMC and BMC methods respectively with PD based MUP 
characterizations. AMC-PD, BMC-PD Probabilistic muscle characterization and the conventional 
methods were studied using the LHS MUP data. 
5.4.2 LHS MUP Data Results 
Table 5.6 shows the mean sensitivity, specificity, accuracy, and SSD across all possible feature sets 
comprised of two, three, four or five features.  
When the results across all feature sets of five were compared, the last column of Table 5.6, the 
AMC-PD Probabilistic method had the highest mean accuracy of 84.5% followed by the Means and 
BMC-PD method whose mean accuracies were 80.3% and 78.8% respectively. The Outlier and 
Combined methods had lower mean accuracy than the Means and Probabilistic methods regardless of 
the number of features in a feature set.  As the number of features used for categorization increased, 
sensitivity increased while specificity decreased for the conventional methods. For example, the 
Outlier method sensitivity increased from 56.8% to 75.9% and specificity decreased from 79.2%% to 
63.2% for two and five features per set respectively. In general, the conventional methods had a 
greater difference between sensitivity and specificity as highlighted by their larger SSD values in 
Table 5.6 compared to the Probabilistic methods. With the Probabilistic methods, sensitivity and 
specificity both increased and demonstrated greater consistency, unlike the conventional methods, as 
the number of features used for categorization increased, e.g. for the AMC-PD method sensitivity 
increased by 3.3% while specificity increased by 5.3% when comparing results of two features per set 
to five features per set. 
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Table 5.7 shows the best five feature sets as sorted by accuracy for each method. The AMC-PD 
method had the feature set with the highest accuracy of 86.3% with 1.1% and 3.3% higher accuracy 
than the BMC-PD and Means method respectively. The AMC-PD method had the feature set with the 
lowest SSD value of 1.8% among all of the top five feature sets of the methods. Also the AMC-PD 
method appears to be more robust against variations in the training data as shown by the generally 
lower SD of accuracy for the top five feature sets. 
The accuracy of the best feature set of the AMC-PD method (86.3%) was higher than that of the 
AMC-LDA and BMC-LDA which were 83.9% and 82.1% respectively.  
All of the feature sets were sorted according to accuracy. A paired t-test was conducted between 
the most accurate feature set and each subsequent feature set in the ordered list starting with the 
second most accurate, to find the feature sets whose accuracy was not different at a 5% level of 
significance.  In Table 5.8 “# feat sets” refers to the number of feature sets per method that had the 
same accuracy at a 5% level of significance. Table 5.8 shows the number of occurrences of each 
individual feature in the feature sets whose accuracy did not differ significantly. Table 5.8 shows that 
the AMC-PD method favoured duration, area and thickness as the most discriminative features while 
the BMC-PD method favoured area, thickness and number of turns and the Means method favoured 
phases, amplitude and area based on the number occurrences in the feature sets whose accuracy did 
not vary significantly. The number of feature sets per method whose accuracy did not vary 
significantly was higher for the AMC-PD and Means methods at 20 and 21 feature sets respectively 
as compared to the other methods. 
Data for the FDI muscle from a patient with a neuropathic disorder, selected from the data 
described in Section 3.2.2, was used to demonstrate the Probabilistic muscle characterization methods 
(see Figure 5.2).  Along the left edge of Figure 5.2, the template waveform and characterization of 
each of the 13 MUPs detected from the FDI muscle are shown. Each MUP characterization is 
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represented by a pie chart where the black area is proportional to the conditional probability that the 
MUP was detected in a neuropathic muscle and the grey area is proportional to the conditional 
probability that the MUP was detected in a normal muscle. The 13 MUPs were sorted in order from 
highest conditional probability of being neuropathic to lowest. For the AMC-PD method the MUP 
characterization values per category were averaged (see Equation 5.3), resulting in a characterization 
measure of 82% in support of a neuropathic condition and 18% in support of a normal condition.  
Using equation 5.4, the BMC-PD method calculated a characterization measure of 100% in support of 
a neuropathic condition and 0% in support of a normal condition.  In both cases this muscle is 
correctly categorized as neuropathic.  The legend has a vertical bar showing the scale that 
corresponds to 1000 µV.  MUP 13 is useful for establishing relative scale because it is the sole MUP 
in the set whose probability of being detected in a normal muscle was higher than being detected in a 
neuropathic muscle. MUPs 1 - 12 in Figure 5.2 have relatively large amplitudes compared to MUP 
13.  
Using the same muscle as in Figure 5.2, Figure 5.3 demonstrates the Means and Outlier methods. 
The asterisk in each plot is where the mean for each feature value for the muscle under examination 
fall. Figure 5.3 shows that mean values of area and thickness are greater than 2 SD above the 
normative training data indicating a neuropathic condition. The Table headed Outlier method in 
Figure 5.3 shows that area and thickness each have three or greater outliers which are both indications 




Figure  5.2  Example FDI Muscle Characterization using Probabilistic Methods 
Clinician Probabilistic Method 
• qualitative • quantitative 
• prone to bias • objective 
• estimations based on examiner experience • MUP characterization estimation based on 
number of  occurrences in exemplary 
training data 
• large cognitive effort needed to 
simultaneously consider multiple feature 
values across many MUPs   
• computer automated 
Data from an FDI muscle whose actual diagnosis is neuropathic was used to demonstrate the 
Probabilistic muscle characterization methods in Figure 5.2. The graphics above can also be used as 
an analogy of how clinicians qualitatively examine EMG signals.  How a clinician performs a 
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qualitative electromyographic examination as compared to the probabilistic method is shown in the 
table in the caption under Figure 5.2. The MUP characterizations in Figure 5.2 were calculated using 
PD with duration, area, and thickness feature values. Area in pie charts shaded in black and grey are 
proportional to neuropathic and normal conditional probabilities respectively.  
 
 
Figure  5.3 Example of Means and Outlier Analysis of an FDI Muscle 
Figure 5.3 demonstrates the Means and Outlier methods using the same muscle as in Figure 5.2. 
The curves for the Means method were drawn assuming a Gaussian distribution of the feature values 
of the MUPs detected from normal muscles.  The mean and standard deviation parameters used for 
drawing the curves were calculated using the mean and standard deviation of feature values as 
described in Section 5.2.2 for the Means method.  The curves are meant to provide an indication of 
the variance of each feature value and not represent their actual distributions because the feature 
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values are not exactly Gaussian distributed, but assumed to be Gaussian for Means analysis. The 
dashed vertical line to the right of the mean of each curve is the mean plus two SD, i.e. the upper 
threshold of the normative training data. The asterisk in each plot is where the mean for each feature 
value for the muscle under examination fell. The mean value of duration across MUPs detected from 
the test muscle is less than 2 SD so it falls in the normative range. The means of area and thickness of 
the test muscle are 12.4 and 2.8 SD higher than the mean value of the normative training data for each 
feature respectively indicating a neuropathic condition. The Table headed Outlier method in Figure 
5.3 shows that area and thickness each have three or greater outliers which are both indications of 




Table  5.6 Average Performance Across All Possible Feature Sets: LHS MUP Data 
Method Mean SD Mean SD Mean SD Mean SD
Sens. 76.2% 7.9% 79.1% 2.6% 79.9% 2.6% 79.5% 2.6%
Spec. 84.2% 7.5% 87.1% 3.4% 88.1% 2.8% 89.5% 2.2%
Acc. 80.2% 7.5% 83.1% 2.3% 84.0% 1.6% 84.5% 0.9%
SSD 4.2% 1.8% 4.2% 1.7% 4.3% 1.8% 5.1% 1.9%
Sens. 76.7% 8.2% 80.2% 3.4% 80.0% 4.0% 77.4% 3.9%
Spec. 82.9% 7.1% 83.4% 4.3% 81.2% 4.2% 80.2% 4.1%
Acc. 79.8% 7.3% 81.8% 2.2% 80.6% 2.7% 78.8% 2.7%
SSD 3.5% 2.0% 3.3% 1.7% 3.5% 1.5% 4.2% 1.2%
Sens. 66.4% 10.3% 73.6% 3.7% 77.0% 2.6% 79.2% 2.0%
Spec. 89.4% 2.1% 86.2% 2.0% 83.6% 1.9% 81.3% 1.7%
Acc. 77.9% 4.8% 79.9% 1.7% 80.3% 1.2% 80.3% 1.1%
SSD 11.5% 5.7% 6.3% 2.4% 3.7% 1.4% 2.6% 0.6%
Sens. 56.8% 14.3% 66.7% 9.1% 72.4% 5.9% 75.9% 4.1%
Spec. 79.2% 4.3% 72.6% 3.9% 67.4% 3.5% 63.2% 3.0%
Acc. 68.0% 6.4% 69.7% 4.4% 69.9% 3.3% 69.5% 2.5%
SSD 11.4% 8.3% 5.2% 3.9% 4.3% 1.5% 6.6% 2.1%
Sens. 71.1% 12.2% 79.2% 4.9% 83.1% 2.8% 85.4% 1.9%
Spec. 74.2% 4.5% 66.7% 3.9% 61.0% 3.3% 56.6% 2.7%
Acc. 72.6% 5.0% 72.9% 2.7% 72.1% 2.2% 71.0% 1.8%
SSD 5.2% 6.0% 6.8% 2.3% 11.0% 2.2% 14.4% 1.5%
# Features used for testing
AMC-PD









Sensitivity increased and specificity decreased for each conventional method (Means, Outlier and 
Combined) as the number of features used for categorization increased. Sensitivity and specificity 
increased or remained steady for the AMC-PD Probabilistic method as the number of features used 
for categorization increased. 
 
Table  5.7 Five Most Accurate Feature Sets per Method: LHS MUP Data 
Method Feature Sets Sens (%) Sens SD Spec (%) Spec SD Acc (%) Acc SD SSD SSD SD
dur      area     thick    phases   turns 84.5% 2.3% 88.1% 1.6% 86.3% 1.5% 1.8% 1.3%
dur      area     thick    turns 83.2% 3.1% 89.3% 2.4% 86.2% 1.8% 3.2% 1.9%
dur      area     thick    phases 84.1% 3.2% 87.8% 2.2% 85.9% 1.8% 2.1% 1.7%
amp      dur      thick    SI       turns 81.8% 2.1% 90.0% 1.0% 85.9% 1.0% 4.1% 1.4%
dur      area     thick    SI 81.8% 3.0% 90.0% 1.6% 85.9% 2.1% 4.1% 1.2%
area     thick    turns 81.4% 3.4% 89.1% 2.5% 85.2% 2.7% 3.9% 1.3%
area     thick 81.4% 3.4% 88.7% 2.5% 85.0% 2.7% 3.7% 1.3%
area     phases   turns 80.5% 2.2% 88.1% 2.0% 84.3% 1.5% 3.8% 1.5%
area     phases 81.4% 3.4% 87.2% 1.8% 84.3% 1.9% 2.9% 1.9%
amp      dur      area     turns 85.5% 4.7% 83.0% 3.2% 84.2% 3.2% 2.2% 1.5%
amp      thick    phases 79.5% 3.9% 86.5% 2.1% 83.0% 2.0% 3.5% 2.4%
amp      area     thick    phases 80.9% 4.2% 84.8% 2.3% 82.9% 2.1% 2.1% 2.5%
amp      dur      area     phases 80.0% 5.7% 85.2% 1.7% 82.6% 2.3% 3.2% 3.0%
amp      dur      phases 77.7% 5.4% 87.4% 1.5% 82.6% 2.2% 5.0% 3.1%
amp      area     thick    SI       phases 80.9% 4.2% 83.9% 2.3% 82.4% 2.2% 2.0% 2.1%
area     SI       turns 77.3% 6.4% 78.0% 3.5% 77.6% 3.3% 3.4% 1.7%
area     SI       phases 77.3% 6.4% 78.0% 3.1% 77.6% 3.6% 3.1% 1.6%
area     SI 72.7% 6.4% 82.2% 3.5% 77.5% 3.5% 5.2% 3.1%
SI       turns 73.6% 5.6% 80.4% 3.3% 77.0% 3.5% 3.6% 2.7%
SI       phases 73.2% 6.2% 80.4% 2.9% 76.8% 3.9% 3.6% 2.9%
area     SI       phases 84.5% 5.3% 73.7% 2.9% 79.1% 3.0% 5.4% 3.1%
SI       phases 79.5% 5.4% 77.2% 2.6% 78.4% 3.2% 2.4% 1.5%
area     SI 80.0% 5.3% 76.5% 3.3% 78.2% 3.0% 2.6% 2.5%
area     phases 76.4% 5.2% 79.1% 2.6% 77.7% 2.3% 2.6% 2.5%














Table  5.8 Number of Occurrences per Feature in Best Feature Sets: LHS MUP Data 
AMC-PD BMC-PD MEAN Outlier Combined
amp      8 5 14 1 3
dur      19 5 10 0 0
area     18 10 14 5 5
thick    13 7 10 0 0
SI       8 5 10 8 8
phases   6 4 21 5 5
turns    9 7 0 4 2
# feat sets 20 15 21 8 9  
The number of occurrences of each individual feature in the feature sets whose accuracy did not differ 
significantly from the most accurate feature set is shown per each method. The term “# feat sets” 




5.5 Rigs MUP Data Results 
The MUP data described in Section 3.2.3 was studied in this section. The AMC characterization 
method was used to analyze the Rigs MUP data and compared to the performance of the conventional 
methods. PD was used to provide MUP characterizations for the AMC rule method. AMC-PD refers 
to using the AMC method using PD based MUP characterizations. 
The same process of training and testing and selecting muscles per trial described in Section 5.4 (LHS 
MUP data) was used for the Rigs MUP data.  
Table 5.9 shows the mean per-category accuracy, overall accuracy, and SSD across all possible 
feature sets comprised of two to five features.  
The conventional methods had lower mean overall accuracy and larger SSD values than the 
AMC-PD method as seen in Table 5.9. Across all feature sets of five, AMC-PD had 10% greater 
accuracy and less than half the SSD than the Mean method which had the highest accuracy of the 
conventional methods.  As the number of features used for characterization increased, myopathic and 
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neuropathic accuracy increased while normal accuracy decreased for the conventional methods, e.g. 
for the Mean method myopathic accuracy increased from 62% to 75% and normal accuracy decreased 
from 89% to 73% for two and five features respectively. With AMC-PD average myopathic accuracy 
increased from 77% to 84% while average neuropathic accuracy remained at 95% across all feature 
sets of two to all feature sets of five. Average normal accuracy increased for the AMC-PD method as 
the number of features increased unlike the conventional methods.  
Table 5.10 shows the best five feature sets as sorted by accuracy for each method. The best 
feature set of the AMC-PD method had 7% higher accuracy than the best feature set of the Mean 
method. The Mean method achieved significantly lower myopathic accuracy than the AMC-PD 
resulting in high values of SSD of the Mean method compared to the AMC-PD method whose SSD 
ranged from 2% to 4%.  All of the feature sets were ranked according to accuracy. A paired t-test was 
conducted between the most accurate feature set and each subsequent feature sets in the ordered list 
starting with the second most accurate, to find the feature sets whose accuracy was not different at a 
5% level of significance.  The Mean methods favoured SI, area, thickness, and turns as the most 
discriminative features, since they occur most frequently in the feature sets whose accuracy did not 
differ significantly. The AMC-PD method favoured thickness, turns and duration as the most 
discriminative features of the feature sets not differing significantly in accuracy.  
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Table  5.9 Average Performance Across All Possible Feature Sets: Rigs MUP Data 
Mean SD Mean SD Mean SD Mean SD
myo 62% 12% 69% 8% 73% 7% 75% 5%
norm 89% 9% 84% 10% 78% 10% 73% 9%
neur 93% 12% 97% 2% 98% 1% 98% 1%
overall 81% 7% 84% 3% 83% 3% 82% 3%
SSD 16% 5% 13% 3% 13% 2% 13% 2%
myo 42% 8% 51% 5% 55% 4% 57% 3%
norm 74% 5% 69% 6% 66% 6% 63% 5%
neur 87% 12% 92% 3% 93% 1% 93% 1%
overall 68% 6% 70% 3% 71% 2% 71% 2%
SSD 20% 4% 17% 2% 17% 2% 16% 1%
myo 60% 11% 63% 7% 65% 5% 65% 5%
norm 69% 7% 61% 8% 56% 7% 51% 6%
neur 93% 14% 97% 3% 98% 2% 98% 1%
overall 74% 8% 74% 3% 73% 2% 71% 2%
SSD 16% 2% 18% 2% 19% 2% 20% 2%
myo 77% 14% 83% 7% 85% 5% 84% 5%
norm 87% 8% 90% 8% 93% 7% 95% 5%
neur 95% 3% 95% 4% 95% 3% 95% 3%
overall 86% 6% 89% 4% 91% 3% 92% 3%
SSD 10% 5% 7% 3% 6% 2% 6% 2%










Table  5.10 Five Most Accurate Feature Sets per Method: Rigs MUP Data 











area     SI       phases 70% 5% 99% 3% 100% 0% 90% 2% 14% 2%
SI       turns 74% 6% 94% 5% 99% 2% 89% 3% 11% 2%
SI       phases 68% 7% 100% 0% 98% 2% 89% 2% 15% 3%
dur      area     SI       turns 82% 5% 83% 7% 100% 0% 88% 2% 9% 2%
area     SI       turns 72% 3% 93% 7% 100% 0% 88% 3% 12% 1%
amp      dur      area     turns 58% 8% 80% 0% 93% 1% 77% 2% 15% 3%
amp      area     turns 57% 9% 80% 0% 93% 1% 76% 3% 15% 4%
area     turns 56% 7% 80% 0% 93% 1% 76% 2% 15% 3%
amp      dur      turns 57% 9% 80% 0% 90% 2% 76% 3% 14% 4%
dur      area     turns 54% 8% 80% 0% 93% 1% 76% 3% 16% 4%
thick    SI 74% 6% 70% 0% 100% 0% 81% 2% 14% 1%
dur      area 60% 6% 79% 3% 100% 0% 80% 3% 17% 2%
dur      area     turns 65% 8% 73% 7% 100% 0% 79% 4% 15% 3%
dur      SI 66% 7% 70% 0% 100% 0% 79% 2% 15% 2%
dur      area     SI 66% 7% 69% 3% 100% 0% 78% 3% 15% 2%
amp      dur      thick    phases   turns 95% 0% 100% 0% 96% 0% 97% 0% 2% 0%
dur      thick    turns 95% 0% 100% 0% 96% 0% 97% 0% 2% 0%
dur      area     thick    phases   turns 92% 3% 100% 0% 98% 3% 97% 1% 4% 2%
amp      thick    turns 95% 0% 94% 7% 100% 0% 96% 2% 4% 2%









5.6 University of Ljubljana Biceps MUP Data 
The performance of the conventional method was compared against the AMC-PD method on the 
Ljubljana biceps MUP data described in Section 3.3.2. This section will also examine the effect of 
using different methods for establishing the normative limits for the Mean method. Previous work in 
this section examined the mean across pooled muscle data (the set of mean muscle values per feature)   
± 2 SD as was discussed in Section 5.2.2. This section also discusses the effect of using broader limits 
for the Mean method by taking the 5th and 95th and then 2.5th and 97.5th percentiles of the pooled 
muscle means because Podnar et al. examined the effect of broader limits of the Mean method on 
sensitivity using the Ljubljana biceps MUP data set studied in this section [51]. The same set of 
features were used as defined for the EAS MUP data in Section 5.4.1 except spike duration was not 
used for testing of the biceps MUP data because it was not available for many of the muscles. 
5.6.1 Ljubljana Biceps Data Results 
The conventional methods had lower mean accuracy and greater difference between sensitivity 
and specificity than the AMC-PD method as highlighted by the large SSD values of the conventional 
methods in Table 5.11. As the number of features used for characterization increased, sensitivity 
increased while specificity decreased for the conventional methods, e.g. for the Mean 2.5th to 97.5th 
percentile method sensitivity increased from 27.1.5% to 58.8% and specificity decreased from 93.9% 
to 84.6% for one and five features per set respectively. The AMC-PD mean sensitivity and specificity 
both increased as the number of features per set increased to 83.3% mean sensitivity, 89.5% mean 
specificity and mean accuracy of 86.4% across all sets of five features.  
Table 5.12 shows the best five feature sets per method as sorted by accuracy. The most accurate 
feature set of the AMC-PD method was 10% more accurate than the best feature set of the Combined 
method which had the highest accuracy of the conventional methods. All of the feature sets were 
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sorted according to accuracy. A paired t-test was conducted between the most accurate feature set and 
each subsequent feature set in the ordered list starting with the second most accurate, to find the 
feature sets whose accuracy was not different at a 5% level of significance.  AMC-PD favoured 
thickness, area and duration as the most discriminative features. The combined method had the 
feature set with the highest accuracy of the conventional methods.  The combined method favoured 
thickness, area and SI as the most discriminative feature sets. 
Table  5.11 Average Performance Across All Possible Feature Sets: Ljubljana Biceps MUP Data 
Mean SD Mean SD Mean SD Mean SD Mean SD
Sens. 18.6% 20.9% 31.5% 19.6% 40.2% 16.6% 46.1% 13.6% 50.2% 11.1%
Spec. 96.5% 1.1% 93.9% 1.7% 91.8% 2.1% 90.0% 2.1% 88.2% 2.0%
Acc. 57.6% 10.7% 62.7% 10.0% 66.0% 8.3% 68.0% 6.6% 69.2% 5.3%
SSD 38.9% 10.2% 31.2% 9.7% 25.8% 8.4% 21.9% 7.1% 19.0% 5.9%
Sens. 33.8% 24.8% 51.4% 17.5% 60.6% 11.3% 65.4% 7.8% 68.1% 6.0%
Spec. 89.1% 2.4% 81.9% 2.3% 77.1% 2.3% 73.9% 2.2% 71.6% 1.9%
Acc. 61.5% 11.5% 66.7% 8.4% 68.9% 5.8% 69.6% 4.2% 69.8% 3.4%
SSD 27.6% 13.3% 15.3% 9.2% 8.5% 5.6% 4.9% 3.3% 3.2% 1.9%
Sens. 27.1% 23.0% 41.9% 17.7% 50.0% 13.6% 55.0% 11.6% 58.8% 10.0%
Spec. 93.9% 3.0% 90.3% 2.6% 88.0% 2.6% 86.1% 2.5% 84.6% 2.1%
Acc. 60.5% 10.2% 66.1% 8.0% 69.0% 6.2% 70.6% 5.3% 71.7% 4.6%
SSD 33.4% 12.9% 24.2% 9.8% 19.0% 7.6% 15.6% 6.5% 12.9% 5.6%
Sens. 28.6% 26.5% 44.4% 22.7% 53.5% 19.0% 59.2% 15.6% 63.0% 11.4%
Spec. 89.3% 3.9% 82.3% 3.6% 77.5% 3.6% 73.9% 3.5% 71.1% 3.0%
Acc. 58.9% 11.9% 63.4% 10.4% 65.5% 8.7% 66.6% 7.0% 67.0% 5.0%
SSD 30.4% 14.7% 19.1% 12.3% 12.7% 9.7% 8.9% 7.4% 6.0% 4.9%
Sens. 32.8% 28.8% 50.4% 22.7% 59.8% 17.6% 65.1% 13.8% 68.2% 10.1%
Spec. 86.6% 4.2% 78.0% 3.5% 72.3% 3.4% 68.1% 3.4% 65.0% 3.0%
Acc. 59.7% 12.8% 64.2% 10.7% 66.0% 8.7% 66.6% 7.0% 66.6% 5.4%
SSD 26.9% 16.1% 14.4% 11.5% 8.4% 7.2% 5.8% 4.7% 4.7% 3.2%
Sens. 72.8% 12.0% 79.4% 6.1% 80.3% 4.8% 80.8% 4.2% 83.3% 4.5%
Spec. 70.3% 17.0% 79.0% 11.6% 85.4% 8.1% 89.5% 4.7% 89.5% 4.0%
Acc. 71.5% 13.7% 79.2% 8.4% 82.8% 5.7% 85.2% 3.7% 86.4% 2.6%
SSD 3.5% 4.2% 3.0% 2.6% 3.7% 2.3% 4.6% 2.0% 4.1% 1.9%
Combined
AMC-PD




Mean 5th to 95th pctle
Mean                     
2.5th to 97.5th pctle






Table  5.12 Five Most Accurate Feature Sets per Method: Ljubljana Biceps MUP Data 
Method Feature Sets Sens (%) Sens SD Spec (%) Spec SD Acc (%) Acc SD SSD SSD SD
dur      area     thick    SI 59% 3% 94% 0% 77% 2% 17% 2%
area     thick    SI 59% 3% 94% 0% 77% 2% 17% 2%
dur      thick    SI 59% 3% 94% 0% 77% 2% 17% 2%
thick    SI 59% 3% 94% 0% 77% 2% 17% 2%
thick 56% 3% 97% 0% 76% 2% 20% 2%
thick    SI 72% 4% 85% 0% 78% 2% 6% 2%
area     thick    SI 73% 5% 82% 1% 77% 3% 4% 2%
thick    SI       turns 72% 4% 82% 0% 77% 2% 5% 2%
area     thick 71% 7% 82% 1% 76% 3% 5% 3%
area     thick    SI       turns 73% 5% 78% 1% 76% 3% 3% 1%
dur      area     thick    SI       turns 66% 4% 88% 0% 77% 2% 11% 2%
area     thick    SI       turns 66% 4% 88% 0% 77% 2% 11% 2%
dur      area     thick    turns 66% 4% 88% 0% 77% 2% 11% 2%
dur      area     thick    SI 66% 4% 88% 0% 77% 2% 11% 2%
area     thick    SI 66% 4% 88% 0% 77% 2% 11% 2%
thick 69% 6% 88% 0% 79% 3% 9% 3%
thick    turns 69% 6% 85% 0% 77% 3% 8% 3%
area     thick    SI 72% 4% 82% 0% 77% 2% 5% 2%
thick    SI 72% 4% 82% 0% 77% 2% 5% 2%
area     thick 72% 4% 82% 0% 77% 2% 5% 2%
thick 75% 4% 85% 0% 80% 2% 5% 2%
area     thick    SI 79% 6% 79% 0% 79% 3% 2% 2%
thick    SI 79% 4% 79% 0% 79% 2% 2% 1%
area     thick 79% 4% 79% 0% 79% 2% 2% 1%
thick    turns 75% 4% 82% 0% 79% 2% 4% 1%
dur      area     thick    phases   turns 87% 2% 94% 1% 90% 1% 3% 1%
dur      area     thick    phases 87% 2% 94% 1% 90% 1% 3% 1%
dur      area     thick    turns 87% 0% 93% 1% 90% 1% 3% 1%
dur      area     thick 87% 0% 93% 1% 90% 1% 3% 1%




MEAN 5th to 95th pctle




5.7 Discussion of Muscle Characterizations 
MUPs with specific feature values (i.e. large area, large amplitude, many turns) can in principle be 
detected in a myopathic, normal or neuropathic muscle, however, with different probabilities. In 
general, single MUPs are nonspecific for different disease states of a muscle. Instead, it is the balance 
or combination of MUP conditional probabilities across a set of MUPs detected in a muscle under 
examination that provides the information regarding the likelihood of the muscle being myopathic, 
normal or neuropathic. Evaluation of a set of MUPs allows the degree to which a diagnostic concept 
matches the set of detected MUPs to be assessed. To be accurate, MUP-based muscle characterization 
must be based on multiple observations that are uncertain, taken by themselves. 
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5.7.1 Comparison of Probabilistic and Qualitative Methods 
Probabilistic muscle characterization is analogous to standard medical practice where a clinician 
qualitatively combines evidence presented by detected MUPs. During qualitative EMG examinations, 
a clinician characterizes each MUP detected and then combines these observations into an overall 
muscle characterization. Probabilistic muscle characterization is based on the same reasoning as used 
for qualitative EMG decisions. 
Probabilistic muscle characterization resembles the methods clinicians use to qualitatively 
examine needle EMG signals. First, a clinician subjectively assesses the similarity of a specific MUP 
under examination to MUPs detected in muscles of specific categories and then implicitly forms an 
estimate of the probability of detecting this MUP in a muscle of a specific category. This is similar to 
the MUP characterizations represented by the smaller pie charts in Figure 5.2. Next the clinician 
combines the probability estimates of all MUPs examined to formulate an overall muscle 
characterization – similar to the muscle characterization represented by the larger pie chart to the right 
in Figure 5.2. However, a clinician may be prone to making biased decisions because they may look 
for MUPs that confirm a pre-conceived expectation or assign lesser importance to MUPs that 
contradict an expectation. As well, there is a possibility of quickly jumping to an incorrect conclusion 
based on the observation of a single MUP feature, (e.g. it is common to associate increased MUP 
amplitude with a neuropathic condition). Probabilistic muscle characterization is a quantitative 
method that uses unbiased MUP characterizations that are estimated by simultaneously considering 
multiple MUP features and based on numbers of occurrences in exemplary training data.  A summary 
of the differences between clinicians using qualitative analysis and Probabilistic methods is provided 
in the caption of Figure 5.2. 
The author believes that skilled electromyographers can achieve similar levels of accuracy as the 
Probabilistic methods during a qualitative examination implying that they can both correctly estimate 
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the MUP conditional probabilities for each MUP (one probability per MUP per category) and can 
successfully combine these probabilities into a single decision. However, it is expected that the speed 
and accuracy with which electromyographers master both of these difficult to acquire skills can be 
increased through the feedback provided by quantitative MUP and muscle characterization. Taking 
into account multiple features simultaneously is a cognitive burden for the electromyographer using 
qualitative methods whereas it is an inherent aspect of Probabilistic muscle characterization. 
5.7.2 Specific MUP Data Sets 
EAS MUP Data 
As the number of features used for characterization increased, sensitivity increased while specificity 
decreased for the conventional methods and remained steady for the BMC-PD method. 
In previous work done by Podnar, area and turns individually had high sensitivity and duration 
had high specificity with the EAS data [47]. When using area, duration and turns simultaneously, 
BMC-LDA method had an almost three percent improvement in accuracy over the combined method 
as shown in Table 5.13. The Means method had very poor sensitivity and very high specificity. Table 
5.13 also shows that this work achieved similar results to those of Podnar [47] in implementing 
conventional analysis.   
Regardless of the method, thickness and turns appeared often in the top five feature sets as 
determined by accuracy. This work agrees with findings reported by Nandedkar et al. for limb 
muscles [35] suggesting that thickness improves accuracy more than area or duration alone but 
disagrees with previous analysis [47, 60] done on the EAS MUP data described in Section 3.3.1 that 
did not find thickness to be more discriminative than area and duration. Previous work using this EAS 
MUP data did not find thickness to be discriminative because not all combinations of feature sets 
were tested in [47, 60]. 
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The BMC–PD method was not as accurate as the BMC–LDA method in the study of the EAS 
MUP data. As shown in Chapter 4, the PD method was marginally less accurate in characterizing 
MUPs than the LDA method. However, the PD method for MUP characterization can provide useful 
information in some cases when used in combination with the BMC–LDA method. An event is 
significant when it occurs more often than expected assuming random occurrence. The significant 
events can be used by the PD method to determine sets of feature values that contributed most to the 
characterization of individual MUPs [61] and can be useful in explaining the basis of a 
characterization of a MUP (i.e. transparency). Although transparency was not the focus of the muscle 
characterization study conducted in Chapter 5, it is important to note that the transparent 
characterization of a MUP can be valuable in situations where the characterization of a MUP 
contradicts a clinician’s initial judgment. In addition, the BMC-PD method is useful for 
characterizing nominal valued features – an ability the LDA method does not have. 
LHS MUP Data 
The AMC-PD method had the highest accuracy across all of the methods evaluated at 86.2%. As the 
number of features used for characterization increased, sensitivity increased while specificity 
decreased for the conventional methods and remained steady for the AMC-PD method. The AMC-
LDA method had slightly lower accuracy than the AMC-PD method. AMC-PD method favoured 
area, duration and thickness as the most discriminative features. 
Rigs MUP Data 
The AMC-PD method had the highest accuracy across all of the methods evaluated at 97%. As the 
number of features used for characterization increased, myopathic and neuropathic accuracy 
increased while normal accuracy decreased for the conventional methods and all three categories 
remained steady or increased for the AMC-PD method. The AMC-PD method favoured duration, 
thickness and turns as the most discriminative features. 
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Ljubljana Biceps MUP Data 
The AMC-PD method at 90% had the highest accuracy across all of the methods evaluated. As the 
number of features used for characterization increased, sensitivity increased while specificity 
decreased for the conventional methods. AMC-PD method favoured area, duration and thickness as 
the most discriminative features. 
5.7.3 Comparison Across MUP Data Sets 
As discussed in Section 3.4 the EAS MUP data set does not have a great deal of separation 
between its categories while the other data sets have a reasonable separation distance.  The accuracy 
of characterizing the EAS MUP data was the lowest and the Rigs MUP data accuracy was the highest 
across all of the MUP data sets consistent with the separation distance of the distributions represented 
by their thickness values as shown in Table 3.1.  
 The BMC–LDA method had better accuracy with lower variance across different feature sets for 
the EAS MUP data than the BMC-PD method. This suggests that the BMC–LDA method may 
provide better estimates of the MUP conditional probabilities than the BMC–PD method for closely 
separated data.  Even though LDA works best for continuous feature values, it was successful in 
using information provided by integer valued features such as number of phases and number of turns 
for the EAS MUP data. 
When there is a reasonable spread in distance between categories as is the case for the LHS MUP 
data, the AMC-PD or BMC-PD methods provided higher accuracy than the AMC-LDA or BMC-
LDA methods. Also AMC-PD based characterization has higher accuracy than BMC-PD methods for 
MUP data sets with reasonable distance of separation.   
AMC-PD performed consistently while the conventional methods performance was not 
consistent across the MUP data sets. The Mean method did not perform well using either the EAS or 
Ljubljana biceps MUP data. For the EAS MUP data the Mean method had very poor sensitivity, i.e. 
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39% average sensitivity across all sets of four features shown in Table 5.3 and a sensitivity of 45.5% 
with the best feature set as shown in Table 5.4.  For Ljubljana biceps MUP data the Mean method 
(using ± 2SD normative limits) had poor sensitivity of 59% with the best feature set as shown in 
Table 5.12. Table 5.12 shows that the sensitivity of the Mean method improves when using wider 
normative limits (5th to 95th percentile), however, the improved sensitivity comes at the cost of 
reduced specificity. Performance of the Mean method did improve for the LHS and Rigs MUP data; 
however, its performance did not exceed the performance of the AMC-PD method. The performance 
of the outlier and the combined conventional methods also had inconsistent performance across the 
MUP data sets. The probabilistic methods performed better than conventional methods across all of 
the MUP data sets. Also sensitivity, specificity and or per category accuracy remained high for the 
AMC-PD and BMC-PD methods regardless of the number of features used for characterization.  
Thickness appeared in all and duration in all but one MUP data set as discriminative features. This 
suggests that duration and thickness should at the very least be included as features in the 
development of a CDSS regardless of the type of muscle or the suspected disease process affecting a 
muscle under examination. 
 
5.7.4 Advantages of the AMC-PD Method 
Pattern Discovery used three intervals to quantize feature values for the LHS and Ljubljana 
biceps MUP data and five intervals to quantize feature values for the EAS and Rigs MUP data. PD 
performed well relative to the other MUP characterization methods examined. Using a small number 
of intervals helps to simplify the visual patterns that explain the results leading to diagrams that are 
easily recognized and understood by clinicians (see Chapter 4). Using a small number of intervals, 
e.g. three, results in a wider range of feature values that are considered small, medium or large. This 
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suggests that for AMC-PD muscle characterization high levels of precision in placing the onset and 
end markers that define the durations of MUPs is not required to ultimately achieve a high level of 
muscle categorization accuracy.  
The results in Table 5.5 provide some indication that the Probabilistic methods are robust to 
changing the size of the training data and varying the composition of the training data. 
A better balance between sensitivity and specificity was obtained by the Probabilistic methods (as 
shown by the lower SSD values) as compared to the conventional methods. This was most likely a 
result of using pattern classification techniques for estimating conditional probabilities of the MUPs. 
Training data from both categories are used so that more information is used for the estimation of 
MUP conditional probabilities.  
Probabilistic muscle characterization is as accurate, or more accurate, than the conventional 
quantitative methods. Probabilistic muscle characterization facilitates the determination of “possible” 
(likely), “probable” (more likely), or “definite” (most likely) levels of pathology [47] whereas the 
conventional methods are based on hypothesis testing and the number of criteria present which is a 
dichotomous “normal” or “abnormal” decision. One can see from Figure 5.2 that the clinician using 
AMC-PD could define numerical intervals that are based on a continuous scale corresponding to 
“possible”, “probable”, or “definite” levels of pathology. AMC-PD is based on quantitative data and 
can be directly used to support clinical decisions related to initial diagnosis as well as treatment and 
management over time. A system based on Probabilistic characterization can also formally combine 
other relevant clinical information to the case at hand such as the characterization of other muscles, 
and non-electrophysiological measurements, symptoms, and or test results. 
The sensitivity and specificity of conventional analysis varied considerably as the number of 
features used for characterization increased. The results showed the dramatic increase in sensitivity as 
the number of features used for the conventional methods increased accompanied by a dramatic 
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decrease in specificity. However, the Probabilistic methods did not vary as the number of features 
used for characterization changed. This property allows more flexibility in the choice of feature sets 
when implementing a system based on Probabilistic methods. 
The conventional Means and Outlier method required a minimum of twenty detected MUPs [47, 
52] testing of a muscle. In this thesis, all of the muscles were tested regardless of the number of 
MUPs detected per muscle except for the EAS MUP data. Allowing all muscles to be tested 
regardless of the number of MUPs detected does not require that the clinician keep looking until a 
minimum of twenty MUPs are found – a potentially difficult task in muscles where a neuropathic 
process reduces the number of motor units.  Note that the AMC-PD method requires a smaller 
number of MUPs to be detected to test a muscle. 
It is expected that Probabilistic characterization can make electrophysiological examinations 
more objective and accurate for most electromyographers. AMC-PD provides more diagnostic 
information than what is provided by conventional muscle characterization techniques. In addition, 
Probabilistic methods are potentially able to provide measures that strongly correlate with the level of 
involvement of a disorder.  Another measure that may strongly correlate with the level of 
involvement of a disorder is described in Chapter 6. The next step performed by the CDSS is to 
convert the scores produced by muscle characterization into well calibrated conditional probabilities 






Table  5.13 Comparison of Area, Duration and Turns Performance: EAS MUP Data 
Sens Spec Acc Sens Spec Acc
Mean 36.4% 86.7% 61.6% 38.0% 88.0% 63.0%
Outlier 46.2% 75.2% 60.6% 43.0% 81.0% 62.0%
Combined 54.2% 73.5% 63.8% 51.0% 79.0% 65.0%
B - PD 70.0% 59.6% 64.8% NA NA NA
B - LDA 66.7% 66.5% 66.6% NA NA NA


















Calibrated Muscle Characterization 
Previous chapters have focused on the accuracy muscle characterization as ratios of predicted 
categories to true categories in sets of test data. A muscle characterization produces a score 
ks between 0 and 1 for each category ky . Characterization accuracy can be expressed as the 
conditional probability of the predicted category, i.e. the category with the largest score value, given 
that the category of a muscle is true as shown in equation 6.1.  
( )trueykissP kik =≠∀> |  (6.1) 
Characterization accuracy is useful information when clinicians are evaluating the performance of 
clinical decision support systems. Chapter 5 has shown that the AMC and BMC methods are accurate 
as defined by equation 6.1 but there was no evaluation of whether the scores ks  produced by the 
AMC and BMC methods were correlated with the level of confidence. A score ks  that is well 
correlated with level of confidence means that the score ks  reflects the probability that the 
characterization is true. Intuitively, if we consider all of the muscles characterized with a score of 
ks =.8, then 80% of these muscles should actually be of the category k. Scores produced by the BMC 
method often saturate to either 0 or 1 as the number of MUPs used for characterization increases, see 
Appendix C for an explanation, so the BMC method is not considered to be well calibrated.  
This chapter will discuss another muscle characterization method known as the Z-transform (ZT) 
method to compare the performance of its calibrated muscle characterizations to the AMC method. 
The chapter will then discuss a method for calibrating scores ks  and then evaluate calibrated scores 




6.1 Z -Transform Muscle Characterization 
The Z transform assumes that the conditional probabilities that comprise MUP characterizations are 
Gaussian distributed. The conditional probability of category c given iMUP  is 
called ( )ici MUPccategoryPP |== . Each ciP  is converted into a normalized z score by subtracting 
the mean across all ciP  and dividing by the standard deviation across all ciP  as shown by equation 6.3. 





Z   (6.3) 
where 
µ  is the mean across all ciP . 
σ is the standard deviation across all ciP . 
The z scores ( ciZ ) are summed across a single category and divided by the standard deviation of the 








  (6.4) 
where 
mcZ is the Z-transform of category c of muscle m across N  MUPs. 
N is the number of MUPs in muscle m . 
The value mcZ is then transformed into a probability )|( mcP by looking up the probability value in 
the Gaussian cumulative density function. More information about the Z-transform can be found in 
[62]. In the rest of this chapter the notation ky will be used to denote a category as has been used 
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earlier in this document. A muscle characterization calculated by the ZT method is a set of 
conditional probabilities.  
Appendix D has a proof that shows that the Z transform of MUP characterizations estimated 
using PD have the same rankings of categories as sorted by their muscle characterization scores as 
compared to the AMC-PD method on a per muscle basis because the Z transform performs a linear 
operation on the AMC-PD characterization. This means that the Z transform method has identical 
sensitivity and specificity as the AMC-PD method for a given MUP data set. A pilot test showed that 
the ZT-PD method had identical sensitivity and specificity as the AMC-PD method using simulated 
MUP data. 
6.2 Category Membership Probability 
The characterization measures calculated by the AMC, BMC or ZT method of a muscle MUS  can be 
thought of as scores ( )MUSsk  for each category ky . Equation (6.2) is called the empirical class 
membership probability [63]. It is equal to the number of muscles with score s that belong to category 
ky divided by the total number of muscles with score s. 
( )( )
( )








=== |  (6.2) 
where  
( )MUSsk  is the score of category ky of muscle MUS   
kks yn =  is the number of muscles with score sMUSsk =)(  whose true category ky=    
kks yn ≠  is the number of muscles with score sMUSsk =)( whose true category ky≠    
A plot of ( )( )sMUSsyP kk =|  versus the score s is called a reliability diagram [64].  A muscle 
characterization method is well calibrated if ( )( )sMUSsyP kk =|  converges to the score 
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value ( )MUSsk . In other words, a muscle characterization method is well calibrated if all points fall 
on the y=x line of the reliability diagram, i.e. the score is well correlated to the level of confidence*.  
In this work, ks  denotes un-calibrated and kŝ denotes calibrated scores. A reliability diagram is 
drawn for each category of a muscle characterization method. A function ( )kk syP |ˆ  is learned for a 
muscle characterization method by finding a fit to the points drawn in its corresponding reliability 
diagrams. An un-calibrated score  ks  is calibrated by changing its value to ( )kkk syPs |ˆˆ = . This 
chapter examines the reliability diagrams of muscle characterization scores and describes the method 
for calibrating the scores in further detail.  
 
6.3 Calibration Method 
The reliability diagram is used for plotting the empirical category membership probability versus 
score for binary (2 category) classification problems. A binary classifier considers an example 
positive if it is a member of the category or negative otherwise. In a multiple category case a 
reliability diagram is drawn for each category where the category under consideration is the positive 
category and all the other categories are considered negative categories. Representing a multiple 
category problem as a set of binary problems is called the one-against-all approach [63].  
                                                     
* Reliability diagrams are often used in the literature to determine the reliability of probability of 
precipitation (POP) estimates provided by weather forecasters [64]. The y value of a reliability diagram for POP 
estimates is determined by counting the number of days precipitation actually fell on those days that the 
POP=x% divided by the total number of days that the POP=x%. The POP values are located on the x-axis. So, 




Mapping scores into probability estimates requires learning a mapping for each category. 
Category membership probabilities ( )sMUSsyP ikk =)(|  are learned by using muscles that actually 
belong to the category as positive categories and all other muscles belonging to the other categories as 
negative. A reliability diagram plots the following set of points for 
category ky ( )( ))(,)(| ikikk MUSsMUSsyP .  
A classification system is well behaved if its scores are well ranked, i.e. if 
)()( jkik MUSsMUSs >  then )|()|( jkik MUSyPMUSyP > . A classifier that ranks well is 
isotonic (monotonically non-decreasing).  Therefore a mapping function that is learned also needs to 
be isotonic.  A common way of learning an isotonic function is called the pair-adjacent-violators 
(PAV) algorithm [63]. This method can take a set of points ( )( ))(,)(| ikikk MUSsMUSsyP  and 
learn an isotonic function ( )kk syP |ˆ  that fits the data using mean-squared error criteria. 
The PAV algorithm learns a function ( )kk syP |ˆ  as follows. The set of category membership 
probabilities ( ){ }N
ikik
syP 1| =  is ordered according to the ranking of their respective scores, in 
mathematical notation ( ) ( )KK 11 +− ≤≤≤ ikkiik sss .  
If ( ) ( )( )1|| −≥ ikkkik syPsyP  then these two points are isotonic and ( ) ( )kikkik syPsyP ||ˆ = . If 
( ) ( )( )1|| −< ikkkik syPsyP  then the two points are known as pair adjacent violators and are both 
replaced by their average i.e. ( ) ( )( ) ( ) ( )( )( ) 2|||ˆ|ˆ 11 −− +== ikkkikikkkik syPsyPsyPsyP . The new 
estimate is checked against previous estimates to ensure that the function has remained isotonic. If 
not, then previous estimates are replaced by averaging until the set becomes isotonic. A Matlab 
function called IsoMeans supplied by Lutz Dumbgen [65] was used to implement the PAV algorithm.  




A score is calibrated by assigning ( )kkk syPs |ˆˆ = , i.e. looking up the y value in the learned 
isotonic functions that correspond to the score. At this stage in the calibration process, the set of 
calibrated scores kŝ  are unnormalized because the sum across all categories is not likely to equal 1. 
These calibrated and unnormalized scores are normalized by dividing each score kŝ  by the sum of 
scores across all categories, i.e. ∑
k
kk ss ˆˆ resulting in normalized calibrated conditional probabilities. 
Figure 6.1 displays an example calibration. The pie chart at the bottom shows an un-calibrated 
muscle characterization of 0.1 myopathic, 0.2 normal, and 0.7 neuropathic. Isotonic functions have 
been learned per category using training data and are labeled ( )scoremyoP |ˆ , ( )scorenormP |ˆ  and 
( )scoreneurP |ˆ  in Figure 6.1 for the myopathic, normal and neuropathic categories respectively.  
The calibrated and unnormalized score for a category is determined by finding the y value associated 
with the un-calibrated score in the isotonic function of that category. This results in calibrated and 
unnormalized scores of 0.03 myopathic, 0.1 normal and 0.85 neuropathic. These scores are 
normalized resulting in a calibrated muscle characterization of 3.1% myopathic, 10.2% normal and 
86.7% neuropathic as shown in the top pie chart. Reliability diagrams for calibrated muscle 
characterizations can be drawn based on the calibrated normalized scores and performance can be 





























( )scorenormP |ˆ ( )scoreneurP |ˆ
 
Figure  6.1  Example of Calibrating Muscle Characterization Scores 
 
6.3.1 Generating Reliability Curves 
Three hundred different runs of training data were created by randomly choosing 450 out of 500 
simulated MUPs per run per category to produce 135,000 MUP characterizations per category. The 
MUP data was characterized using PD to produce three conditional probabilities for each MUP. In 
total, 405,000 MUP characterizations were generated. Equal number of virtual muscle data per 
category was created by randomly selecting MUP characterizations out of the 135,000 MUP 
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characterizations. Four different sets of 60,000 virtual muscles per category were created where each 
set was composed of 1, 2, 5 and 10 MUPs respectively per virtual muscle. The sets that had 1 and 2 
MUPs per virtual muscle were generated without replacement from the pool of MUP 
characterizations as 135,000 MUP characterizations is greater than 2 x 60,000. However, sets that had 
5 and 10 MUPs per virtual muscle were sampled with replacement from the pool of MUP 
characterizations. Reliability diagrams of average muscle characterization were compared to Z-
Transform muscle characterizations for each of the four sets and per category.  
The same process described in the previous paragraph was repeated for the remaining MUP data 
sets described in Chapter 3 and was done by randomly choosing approximately 90% of the available 
MUPs per training run and repeating until 135,000 MUP characterizations per category were 
generated. Four sets of 60,000 virtual muscles per category were generated for each MUP data set 
where each set was composed of 1, 2, 5 and 10 MUPs respectively per virtual muscle. Reliability 
diagrams for virtual muscles with greater than 10 MUPs were not drawn because of the tendency of 
the reliability curves to saturate into sharp sigmoid shapes resembling the shape just before, during, 
and after the rising edge of a square wave. 
Reliability diagrams were drawn by using equation 6.2 for the un-calibrated and calibrated scores.   
The mean square error of un-calibrated scores denoted uncalMSE  and calibrated scores 
denoted calMSE were calculated across all N points in a reliability diagram by squaring the difference 



































6.4 Calibrated Muscle Characterization Results 
Un-calibrated MSE increases as the number of MUPs per virtual muscle increases regardless of the 
data set studied as shown in Tables 6.1 to 6.5. A line fitted through the un-calibrated data points in the 
reliability diagrams resembles a sigmoid shape where the slope of the middle section of the sigmoid 
increases as the number of MUPs per virtual muscle increases. Regardless of the category the MSE 
for every MUP data set becomes smaller for calibrated data in the reliability diagrams as compared to 
the un-calibrated data.  
The MSE of the ZT muscle characterization method did not differ a great deal from the MSE of 
the AMC method for MUP data sets that had two categories (LHS, EAS and LJUB-Biceps) as shown 
in Tables 6.1 to 6.3. A line fitted through the points in the reliability diagrams shows that both the 
calibrated AMC and ZT methods approximately follow the y=x line. Figures 6.2 and 6.3 show the 
reliability diagrams for neuropathic data using the AMC method for the EAS and LHS MUP data 
respectively.  
The MSE of the un-calibrated and calibrated ZT muscle characterization method was usually less 
than the MSE of the un-calibrated and calibrated AMC method for MUP data sets that had three 
categories (simulated and Rigs) for virtual muscles with 5 and 10 MUPs as shown in Tables 6.4 and 
6.5. For the simulated MUP data the MSE of the calibrated ZT method averaged about 60% and 42% 
of the MSE of the calibrated AMC method across the categories for 5 and 10 MUPs per virtual 
muscle respectively for the simulated MUP data.   A line fitted through the points in the reliability 
diagrams showed that the ZT method follows closer to the y=x line than the AMC method when 
comparing results for the same number of MUPs per virtual muscle for the simulated data. For the 
Rigs MUP data the MSE of the calibrated ZT method was less than the calibrated AMC method 
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except for the Neuropathic category. Figures 6.4 and 6.5 show the reliability diagrams for the 
calibrated AMC and ZT methods for the Rigs myopathic and neuropathic categories respectively. As 
shown in Table 6.4 the greatest decrease in MSE of the ZT method as compared to the AMC method 
for the calibrated neuropathic scores occurred when using 10 MUPs per virtual muscle. The majority 
of the points as shown in Figure 6.5 for virtual muscles of 5 and 10 MUPs are clustered towards 0 or 
1 for both the calibrated AMC and ZT methods thus not leaving a great deal of points in between to 
get a good sampling of  the range of scores.  
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NEUR using AVERAGE with features thick/SI/turns 1 per mus
 
 
 Total Number of Points = 593
 MSE = 0.0012676
PD

























NEUR using AVERAGE with features thick/SI/turns 2 per mus
 
 
 Total Number of Points = 600
 MSE = 0.0034763
PD

























NEUR using AVERAGE with features thick/SI/turns 5 per mus
 
 
 Total Number of Points = 600
 MSE = 0.017225
PD

























NEUR using AVERAGE with features thick/SI/turns 10 per mus
 
 
 Total Number of Points = 600
 MSE = 0.039635
PD

























NEUR using ISO (normalized) with features thick/SI/turns 1 per mus
 
 
 Total Number of Points = 150
 MSE = 0.00094646
PD

























NEUR using ISO (normalized) with features thick/SI/turns 2 per mus
 
 
 Total Number of Points = 150
 MSE = 0.0012576
PD

























NEUR using ISO (normalized) with features thick/SI/turns 5 per mus
 
 
 Total Number of Points = 207
 MSE = 0.0011327
PD

























NEUR using ISO (normalized) with features thick/SI/turns 10 per mus
 
 
 Total Number of Points = 233
 MSE = 0.0010998
PD
























































































































































Figure  6.2 Reliability Diagrams for Un-calibrated & Calibrated Neuropathic EAS MUP data 
Characterizations using AMC 
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NEUR using AVERAGE with features dur/area/thick/turns 1 per mus
 
 
 Total Number of Points = 546
 MSE = 0.0062403
PD

























NEUR using AVERAGE with features dur/area/thick/turns 2 per mus
 
 
 Total Number of Points = 600
 MSE = 0.010584
PD

























NEUR using AVERAGE with features dur/area/thick/turns 5 per mus
 
 
 Total Number of Points = 600
 MSE = 0.059276
PD

























NEUR using AVERAGE with features dur/area/thick/turns 10 per mus
 
 
 Total Number of Points = 600
 MSE = 0.098495
PD

























NEUR using ISO (normalized) with features dur/area/thick/turns 1 per mus
 
 
 Total Number of Points = 145
 MSE = 0.0016185
PD

























NEUR using ISO (normalized) with features dur/area/thick/turns 2 per mus
 
 
 Total Number of Points = 216
 MSE = 0.00079853
PD

























NEUR using ISO (normalized) with features dur/area/thick/turns 5 per mus
 
 
 Total Number of Points = 218
 MSE = 0.00057602
PD

























NEUR using ISO (normalized) with features dur/area/thick/turns 10 per mus
 
 
 Total Number of Points = 153
 MSE = 0.00026338
PD








































































































































































































































































































Figure  6.3 Reliability Diagrams for Un-calibrated & Calibrated Neuropathic LHS MUP Data 
Characterizations using AMC 
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MYO  using ISO (normalized) with features dur/thick/turns 1 per mus
 
 
 Total Number of Points = 545
 MSE = 0.00078889
PD

























MYO  using ISO (normalized) with features dur/thick/turns 2 per mus
 
 
 Total Number of Points = 592
 MSE = 0.0014265
PD

























MYO  using ISO (normalized) with features dur/thick/turns 5 per mus
 
 
 Total Number of Points = 535
 MSE = 0.0030521
PD

























MYO  using ISO (normalized) with features dur/thick/turns 10 per mus
 
 
 Total Number of Points = 412
 MSE = 0.0057641
PD

























MYO  using ISO (normalized) with features dur/thick/turns 1 per mus
 Total Number of Points = 530





























MYO  using ISO (normalized) with features dur/thick/turns 2 per mus
 Total Number of Points = 592





























MYO  using ISO (normalized) with features dur/thick/turns 5 per mus
 Total Number of Points = 550





























MYO  using ISO (normalized) with features dur/thick/turns 10 per mus
 Total Number of Points = 386












































































































































































































































































































Figure  6.4 Reliability Diagrams for Calibrated Myopathic  Rigs MUP Data Characterizations 
using AMC & ZT 
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NEUR using ISO (normalized) with features dur/thick/turns 1 per mus
 
 
 Total Number of Points = 523
 MSE = 0.00072889
PD

























NEUR using ISO (normalized) with features dur/thick/turns 2 per mus
 
 
 Total Number of Points = 595
 MSE = 0.0011804
PD

























NEUR using ISO (normalized) with features dur/thick/turns 5 per mus
 
 
 Total Number of Points = 514
 MSE = 0.0010252
PD

























NEUR using ISO (normalized) with features dur/thick/turns 10 per mus
 
 
 Total Number of Points = 226
 MSE = 0.0012828
PD

























NEUR using ISO (normalized) with features dur/thick/turns 1 per mus
 Total Number of Points = 517





























NEUR using ISO (normalized) with features dur/thick/turns 2 per mus
 Total Number of Points = 586





























NEUR using ISO (normalized) with features dur/thick/turns 5 per mus
 Total Number of Points = 527





























NEUR using ISO (normalized) with features dur/thick/turns 10 per mus
 Total Number of Points = 220












































































































































































































Figure  6.5 Reliability Diagrams for Calibrated Neuropathic  Rigs MUP Data Characterizations 




Table  6.1 MSE of Calibrated & Un-calibrated LHS MUP Data 
x10E-3 AMC ZT AMC ZT
NORM1 6.9 4.2 1.7 2.2
NORM2 10.6 11.6 0.7 0.7
NORM5 59.3 54.7 0.6 0.6
NORM10 98.5 96.7 0.3 0.3
NEUR1 6.2 3.0 1.6 1.6
NEUR2 10.6 11.6 0.8 0.8
NEUR5 59.3 54.7 0.6 0.6
NEUR10 98.5 96.7 0.3 0.3
Uncalibrated Calibrated
MSE of LHS Data
 
 
Table  6.2 MSE of Calibrated  & Un-calibrated EAS MUP Data 
x10E-3 AMC ZT AMC ZT
NORM1 1.2 1.1 0.8 0.8
NORM2 3.5 4.0 1.6 1.6
NORM5 17.2 19.7 1.0 1.0
NORM10 39.6 46.5 1.0 1.0
NEUR1 1.3 1.2 0.9 1.0
NEUR2 3.5 4.0 1.3 1.3
NEUR5 17.2 19.7 1.1 1.1
NEUR10 39.6 46.5 1.1 1.1
CalibratedUncalibrated 




Table  6.3  MSE of Calibrated & Un-calibrated Ljubljana Biceps MUP Data 
x10E-3 AMC ZT AMC ZT
MYO1 3.8 2.8 1.9 1.9
MYO2 11.3 12.4 0.7 0.7
MYO5 61.6 61.3 0.6 0.6
MYO10 108.5 118.6 0.3 0.3
NORM1 3.7 2.7 1.1 1.1
NORM2 11.3 12.3 1.2 1.2
NORM5 61.6 61.3 0.5 0.5
NORM10 108.5 118.6 0.6 0.6





Table  6.4 MSE of Calibrated and Un-calibrated Simulated MUP Data 
x 10E-3 AMC ZT AMC ZT
MYO1 2.2 2.5 1.2 1.4
MYO2 15.9 14.2 1.5 1.3
MYO5 57.2 29.2 0.9 0.6
MYO10 78.8 28.2 1.0 0.4
NORM1 1.5 2.9 1.1 1.2
NORM2 16.6 14.0 1.4 1.5
NORM5 66.8 37.8 1.7 0.9
NORM10 103.1 44.6 2.1 0.8
NEUR1 3.0 3.5 1.1 1.3
NEUR2 13.6 12.4 1.2 1.1
NEUR5 52.8 25.0 1.2 0.7






Table  6.5 MSE of Un-calibrated  & Calibrated Rigs MUP Data 
x 10E-3 AMC ZT AMC ZT
MYO1 1.0 2.2 0.8 0.8
MYO2 10.4 9.1 1.4 1.3
MYO5 47.3 26.3 3.1 1.8
MYO10 80.3 43.0 5.8 2.2
NORM1 1.2 0.9 0.7 0.5
NORM2 10.1 7.7 1.2 1.3
NORM5 51.4 32.0 2.7 1.7
NORM10 92.9 55.2 4.5 1.8
NEUR1 2.6 2.2 0.7 0.8
NEUR2 11.5 9.7 1.2 1.4
NEUR5 51.6 21.4 1.0 1.1






Based on the results the AMC or ZT method for muscle characterization are recommended.  The ZT   
method achieves the lowest MSE scores for the three category data sets and equals the performance 
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of the AMC method for two category data sets. The neuropathic category of the Rigs MUP data was 
the only data where the ZT method performed slightly worse than the AMC method. The author of 
this thesis believes that this is due to the polarized clustering of points by the ZT to be near zero or 1 
so that not enough points in between 0 and 1 remained to get a robust measure of MSE. 
The method presented in this chapter appears to calculate calibrated scores that are reliable, i.e. 
reflective of their true underlying conditional probabilities. A clinician would have greater trust in a 
system that produces reliable conditional probabilities fulfilling an important requirement of a CDSS 
– Section 2.3 under “Report Confidence”. A clinic could establish a threshold of conditional 
probability that needs to be exceeded before declaring an abnormality. Calibrated conditional 
probability could be quantized into “possible”, “probable”, or “definite” levels of abnormality useful 
information for helping a clinician decide whether further testing is required or whether treatment can 
be applied.   In addition, calibrated conditional probabilities could be an indication of the level of 
involvement of a disorder and could be used to examine the effectiveness of treatments in 
longitudinal studies.  A system that produces reliable conditional probabilities is also transparent in 
that the system reports for each muscle characterization its level of confidence.  
The low MSE scores shown in Tables 6.1 to 6.5 for un-calibrated scores of muscle 
characterizations using 1 MUP and the upper left reliability diagrams of Figure 6.2 and 6.3 show that 
the un-calibrated PD scores are well calibrated by how close the reliability diagram follows the y=x 
line. The un-calibrated scores of muscle characterizations using greater than 1 MUP are not reflective 
of their underlying conditional probabilities as shown by the increasingly sharper sigmoid shapes and 
higher MSE values as the number of MUPs used for muscle characterization increases.  
The un-calibrated reliability diagrams in Figure 6.2 show the effect of data that does not have a 
great deal of separation between categories. Because of the ambiguity of the EAS MUP data set there 
were very few scores lower than 0.4 and scores greater than 0.7. For data sets with good separation 
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between categories there appears to be a more uniform distribution of points across all values of 
scores as shown in the un-calibrated column of Figure 6.3. 
It appears from the results that the performance of calibrating three category data sets (simulated 
and Rigs) is poorer than two category data sets (EAS, LHS and LJUB-Biceps) especially as the 
number of MUPs per muscle increases. The method proposed in this chapter considers one category 
at a time to draw binary reliability diagrams and then learning an isotonic function. It seemed to work 
well for the two category data sets because the mapping occurs between one-dimensional spaces. In 
reality, the three category case is a mapping of a two-dimensional space to another two-dimensional 
space. Breaking the three category problem into separate one-dimensional problems and the 
normalization has likely led to a loss of information and therefore poorer results than for the two 
category data sets. 
6.5.1 Application 
The following is an initial proposal as to how a clinic conducting EMG examinations could provide 
calibrated muscle characterizations. A clinic would have control over their labeled training data. 
Examinations using the CDSS would be consistent with their definition of abnormality.   
Training Phase 
1. Collect MUP data from patients visiting the clinic. 
2. Patients with confirmed diagnosis could have their MUP data labeled as myopathic or 
neuropathic. 
3. Confirmed healthy subjects are used to establish normal data to have a definition of 100% 
normal. It is recommended that subjects referred to the clinic for neuromuscular symptoms 
and then cleared by the clinic as being healthy are not to be used to establish normal training 
data as their data may not be representative of a healthy subject. 
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4. Features extracted from MUPs are pooled into the following sets: myopathic, normal and 
neuropathic. 
5. Random selection as described in Section 6.3.1 with the pooled MUP data (step 4 above) is 
used to generate a reliability curve for each category and for the following numbers of MUPs 
per virtual muscle { }10,9,,2,1 Kεn . 
6. An isotonic function is learned from the reliability curves generated in step 5 leading to thirty 
learned functions (3 categories x 10 different sets of n MUPs/virtual muscle). 
Clinical Examination of a Patient 
1. A muscle from a patient under examination is characterized using the ZT-PD method. The 
number of MUPs n detected and used for characterization is noted. 
2. The set of isotonic functions learned during the training phase that correspond to n MUPs are 
used to obtain a calibrated muscle characterization. 
 
There are unresolved issues with the process discussed above. Usually greater than 10 MUPs will be 
detected from a muscle under examination. Drawing reliability curves for greater than 10 MUPs is 
not recommended because they saturate into a sharp sigmoid shape with a slope of the rising edge 
approaching infinity. This saturated sigmoid shape would lead to calibrated scores of either 0, 
indeterminate (for portion approaching infinite slope) or 1. The MSE of reliability diagrams of 
calibrated scores cannot be accurately determined because the calibrated scores are clustered at either 
0 or 1 and the entire range of scores is not sufficiently sampled to obtain a statistically robust MSE 
(see reliability diagram bottom right of Figure 6.3 for an example).  
Here are some possible strategies for doing calibrated muscle characterizations when the number 
of MUPs detected per muscle is greater than 10. The following strategies need to be tested for 
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accuracy as in chapter 5 and for the MSE of their calibrated reliability curves as described in this 
chapter. 
• Use only 10 randomly selected MUPs to use for calibration or 
• Rank the MUP characterizations by their MUP conditional probabilities of the 
category with the highest score. Divide the ordered set of MUP characterizations into 
sets of 10 and calibrate each set. Average the calibrated scores across these sets to 
produce an overall calibrated muscle characterization or 
• Use the functions learned for 10=n  to calibrate any raw muscle characterization 
score where 10>n  or 
• Generate reliability curves for all values of n up to a upper limit say 60 and use the 







This work recommends using PD based MUP characterizations and transforming a set of MUP 
characterizations into a muscle characterization using the AMC or Z-transform method. Finally, 
AMC or the ZT transform can be calibrated by learning an isotonic function for each category using 
the PAV algorithm and then converting the score into a calibrated conditional probability of a 
neuromuscular category given the MUPs detected from a muscle.  
The AMC-PD or ZT-PD method can be directly used to support clinical decisions related to initial 
diagnosis as well as treatment and management over time. Decisions are based on facts and not 
impressions giving electromyography a more reliable role in the diagnosis, management, and 
treatment of neuromuscular disorders. AMC-PD or ZT-PD based muscle characterization can help 
make electrophysiological examinations more accurate and objective. 
7.1 Success in Meeting the Requirements  
This work cannot completely answer the question: does the CDSS improve a clinician’s 
performance? This question is more important than determining the accuracy of the characterizations 
provided by a CDSS as a stand-alone system and is addressed in the Future work section of this 
chapter. The function of the CDSS is to provide a characterization. It is the role of the clinician to 
transform the characterization into a categorization. Currently clinicians use mostly manual methods 
to recognize patterns created by MUP features and MU activation. The acceptance of a CDSS by 
clinicians depends on its ability to provide a new point of view that reveals rules or relationships 
easily seen as well as not easily seen by their current methods. 
 
 117 
The section will provide conclusions on the recommended CDSS design against the requirements 
listed in Section 2.3.  
7.1.1 Transparency 
MUP characterization using PD was found to be transparent because it explained its characterizations 
by reporting sets of feature values along with a strength-of-evidence measure supporting or refuting 
its characterizations. Calibrated muscle characterizations methods in this work can explain their 
characterizations by ranking the MUPs as sorted by conditional probability of the category with the 
highest characterization measure. Muscle characterizations were not as transparent as individual MUP 
characterizations because muscle characterizations require a large amount of information to be 
integrated into an underlying explanation, see for example Figure 5.2.  
7.1.2 Accuracy 
AMC-PD based muscle characterizations had higher sensitivity and specificity than conventional 
muscle characterization methods. It uses the same information available during qualitative 
examination except it produces consistent, objective evidence while not being dependent on intuition, 
and biased by other sources of information. As a decision support system, it can aid an 
electromyographer in a single but important step of an EMG examination and can provide an 
objective record over time that facilitates longitudinal studies.  
7.1.3 Confidence 
According to the reliability curves in Chapter 6, the AMC-PD or ZT-PD method can be calibrated 
into a probability estimate that corresponds to confidence. Clinicians can understand the reliability of 
an individual characterization and perhaps use confidence thresholds to declare that a patient has an 
abnormality, e.g. only calibrated probability estimates of greater than 90% should confirm the 
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presence of a category of abnormality and estimates of less than 90% require further testing or 
revision of the hypothesis as to the underlying cause of a patient’s symptoms. 
7.1.4 Generalization 
The methods for training and testing were done using jackknifing across a number of different trials. 
As well, several different MUP data sets were studied. The AMC-PD and hence the ZT-PD method is 
accurate across different MUP data sets - even for data such as the EAS MUP data set that does not 
have a great deal of separation between the categories.  
7.1.5 Handle Missing Data 
The effect of missing data was not studied in this work. 
 
7.2 Research Contributions 
In the author’s opinion, the original contributions of this work are: 
1. Methods for doing PD based MUP characterizations were implemented and evaluated. 
2. Methods for AMC-PD based muscle characterizations were developed and evaluated. The AMC-
PD method exceeds the performance of conventional muscle characterization techniques as per 
the requirements of a CDSS. 
3. The PAV method for calibrating the AMC-PD and ZT-PD muscle characterization methods were 
implemented and evaluated.  
4. An equation for transforming WOE into conditional probabilities was derived. 
5. The thesis suggests that different muscle types can be pooled together for training and testing data 
and found to provide reasonable accuracy. 
6. A graphical method of displaying MUP characterizations in a transparent manner was developed. 
 
 119 
7.3 Future Work 
7.3.1 Graphical User Interface (GUI) 
The methods developed and recommended in this work should be built into a system capable of being 
used in a clinical setting.  Feedback about the usability and effectiveness of CDSS prototypes with the 
developed GUI should be sought from clinicians that conduct EMG examinations.  
7.3.2 ZT-PD Method 
Other MUP data sets that have three or more categories should be examined as to the reliability 
diagrams produced by the AMC and ZT methods. The ZT method may provide better calibrated 
conditional probabilities than the AMC method in terms of low MSE score in a reliability diagram as 
the number of categories to be characterized increases. 
If the ZT method does not perform well for greater than three categories then finding a method 
that can perform well for higher dimensional calibration may be a worthwhile research project. 
 
7.3.3 Transparent Muscle Characterization 
Although a demonstration of the transparency of MUP characterizations was provided, a method that 
can provide a transparent muscle characterization would be useful.  
7.3.4 Correlation to Level of Involvement 
The characterization measures of the AMC method showed excellent correlation to level of 
involvement of neuropathic and myopathic neuromuscular disorders when analyzing 
electromyographic signals based on the simulated MUP data described in this thesis[66]. Verifying 
that the calibrated conditional probability estimates produced are correlated with the level of 
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involvement of a disorder for clinical data would be useful. This is challenging because it is difficult 
to accurately know the level of a disorder for a real muscle. 
7.3.5 Addition of Other Electrophysiological Features 
Other features should be considered and evaluated. Both new shape and or size based features as well 
as features derived from firing patterns of MUs. As well, integrating results from other QEMG 
methods into an overall system may be possible and useful. 
7.3.6 Examination of Accuracy versus Number of MUPs 
It would be worthwhile to examine the effect of using less than the total number of MUPS detected to 
determine a muscle characterization and to see the effect of reducing the number of MUPs on 
accuracy. This may allow clinicians to complete examinations more quickly if they can obtain an 
accurate muscle characterization with fewer MUPs.  
7.3.7 Clinical Evaluation 
Friedman et al. describes the results of a trial on how two different CDSS systems enhance or 
degrade diagnostic reasoning [67]. The study describes a consultation as positive when the clinician 
made a correct diagnosis after a CDSS consultation but did not include it in their initial diagnosis of 
the same data. A consultation is negative when the clinician made the correct diagnosis in their initial 
diagnosis but reversed it after consultation with the CDSS. There should be a net gain of positive 
consultations versus negative consultations to consider the CDSS as a success in enhancing 




Derivation of Compound Rule Conditional Probability for PD 
MUP =  yk  MUP was detected in a muscle of category ky  
MUP ≠  yk  MUP was not detected in a muscle of category ky  
*
kx   compound rule associated with category ky  
WOE   Weight of Evidence 
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Definition of conditional probability. 













*     (A.2)  
Total Law of Probability. 
( ) ( ) ( ) ( ) ( )kkkkkkk yMUPPyMUPxPyMUPPyMUPxPxP ≠⋅≠+=⋅== || ***  (A.3) 
Rearrange A.3 













*    (A.4) 
Sum of all prior probabilities equals 1. 
( ) ( ) 1=≠+= kk yMUPPyMUPP    (A.5) 
Sub A.5 into A.4 



















Sub A.2 into A.6 














*   (A.7) 
 
Sub A.2 and A.7 into A.1 
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=Φ   (A.9) 
Sub A.9 into A.8 
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 Derivation of Bayes Rule for Multiple Pieces of Evidence 
In both (Pfeiffer. 1999) and this paper, we are using Bayes theorem for combining the evidence of 
multiple MUPs. All of the feature values of a single MUP can be thought of as a single piece of 
evidence e. Pfeiffer used the recursive form of Bayes theorem which is used to update the posterior 
probability as new evidence appears. In this paper, the form of Bayes formulae that is used is called 
“Bayes Theorem for Multiple Pieces of Evidence” and is identical to the recursive form of Bayes 
theorem when all pieces of evidence have been collected and the recursion is finished. Below shows 
how Bayes theorem is derived for multiple pieces of evidence under the assumption that each piece of 
evidence is conditionally independent of the other pieces of evidence. First, we start with Bayes 
theorem for a single piece of evidence and multiple categories. More information about Bayes 
Theorem for multiple pieces of evidence can be found in: 
Duda R, Hart PE. Pattern Classification. 2nd edition. John Wiley and Sons, Inc. 2001.  
 
Bayes Theorem – One piece of evidence & Multiple Categories 
 
i
Y = Category i, { }1, ,i K∈ K  
e   = Single piece of evidence 
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=  (B.1) 
 
Total Law of Probability assuming each category forms a disjoint set, e.g. a muscle in the training 
data can only belong to one category. 
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Bayes Theorem – Multiple pieces of evidence & Multiple Categories 
 
i
Y = Category i, { }1, ,i K∈ K  
j
e    = Piece of evidence j, { }1, ,j n∈ K  
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Total Law of Probability assuming each category forms a disjoint set. 
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If we assume conditional independence of the evidence, i.e. the pieces of evidence are statistically 
independent given a category then: 
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Equation B.8 above shows the form of Bayes theorem for multiple pieces of evidence when the pieces 
of evidence are statistically independent given a category.  
 
Derivation of Bayes Rule for Muscle Characterization 
Start with equation B.8 and substitute in muscle category and MUPs for pieces of evidence. 
( )
( ) ( )
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Rearrange Bayes rules for a single piece of evidence 
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Assume that all prior probabilities are equal, i.e. ( ) ( ) ( ) KyPyPyP K 102010 ==== K  
 



































Saturation of Bayes’ Muscle Characterization 
 
Appendix C shows that the Bayesian muscle characterization technique converges to 1 or 0 as the 
number of MUPs used for characterization increases.  
 
Two category { }21, yy muscle categorization will be considered.  
 
Say that we start with the following MUP characterization for a muscle: 
 
( ) ε+= 5.0| 11 MUPyP  (C.1) 
( ) ε−= 5.0| 12 MUPyP  (C.2) 
 
N MUPs are found such that they all have the same MUP characterizations: 
 
( ) ( ) ( ) ε+==== 5.0||| 12111 NMUPyPMUPyPMUPyP K   (C.3) 
( ) ( ) ( ) ε−==== 5.0||| 22212 NMUPyPMUPyPMUPyP K   (C.4) 
 
Using Equation 5.4 and setting its denominator = den  
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Consider the ratio of C.5 to C.6 to consider how quickly one conditional probability grows with 




















Equation C.7 shows that R approaches ∞ as N approaches ∞ for positives values of ε . This means 




Proof that Z-transform Provides Same Ranking as Averaging 
Appendix D is a proof that shows that the Z transform of MUP characterizations has the same ranking 
of categories as sorted by their muscle characterization scores as compared to the AMC-PD method 
on a per muscle basis. 
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  (D.4) 
So if: KAMCAMCAMC <<< K21  
then KZZZ <<< K21  because D.4 is a linear scaling and shifting of kAMC . Hence AMC  has 
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